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ABSTRACT
The purpose of this dissertation was to elucidate the regulation of skeletal muscle 
oxygen (O2) supply and demand and determine their influence on physical function in 
health and disease. In the first study, motivated by the theory that heat generated by a 
muscle attunes O2 supply to metabolic demand, we explored the mechanisms by which 
moderate heat inhibits a-adrenergic vasocontraction in isolated human skeletal muscle 
feed arteries. Of note, the previously recognized sympathoinhibitory effect of heat on a 1- 
adrenergic vasocontraction could be prevented by inhibiting the temperature-sensitive 
TRPV4 ion channels or by endothelial denudation, which indicates that TRPV4 ion 
channels contribute to this response in an endothelium-dependent manner. In the second 
study we sought to determine if qualitative changes in mitochondrial O2 consumption 
contribute to the exercise intolerance exhibited by patients with chronic obstructive 
pulmonary disease (COPD). Compared to that of healthy controls, permeabilized muscle 
fibers from the vastus lateralis of patients with COPD exhibited a reduced mitochondrial 
respiratory capacity that was related to a less-efficient pattern of respiration. Importantly, 
this altered pattern of respiration, which likely demands more O2 to resynthesize 
adenosine triphosphate (ATP), was correlated with knee extensor (KE) endurance among 
patients, suggesting that altered mitochondrial O2 demand contributes to exercise 
intolerance in COPD. In the third study, inspired by the theory of symmorphosis, which 
postulates that no single step of the O2 cascade restricts maximal skeletal muscle O2 
consumption (VO2max), we investigated the role of O2 supply and demand in determining
VO2max in endurance exercise-trained and untrained humans by comparing in vivo 
(skeletal muscle VO2max, direct Fick) and in vitro (permeabilized muscle fiber 
mitochondrial VO2max) measures of respiratory capacity. Interestingly, skeletal muscle 
VO2max of untrained subjects was limited by mitochondrial O2 demand, while in trained 
subjects, who exhibited a training-induced mitochondrial reserve, VO2max was limited by
O2 supply. These findings challenge the concept of symmorphosis by clearly revealing 
unique constraints to VO2max in untrained and trained humans. In summary, this set of 
studies helps to elucidate the mechanisms that regulate O2 supply and demand, and 
clarifies the influence of these factors on physical function in health and disease.
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CHAPTER 1 
INTRODUCTION
In a coordinated chain of events, known as the O2 cascade, multiple systems and 
processes function together to deliver atmospheric O2 to the mitochondria of skeletal 
muscle and other organs to facilitate ATP resynthesis through oxidative phosphorylation. 
The O2 cascade begins with the lungs, which take in air allowing the diffusion of ambient 
O2 through the alveoli into the blood. The cardiovascular system then directs the O2-rich 
blood to the organs. In the skeletal muscle, the O2 diffuses through the sarcolemma into 
the cells, ultimately reaching its destination, the mitochondria, where it participates in 
oxidative phosphorylation (Rowell, 1992; Richardson, 1998). For simplicity, the steps of 
the O2 cascade can be generalized into two components: O2 supply to the mitochondria 
and O2 demand or consumption by the mitochondria.
While much is understood about the O2 cascade, the mechanisms behind certain 
processes and implications of alterations in O2 supply and demand remain uncertain. 
Therefore, the purpose of this dissertation was to examine three separate, yet related, 
topics regarding O2 supply and demand during exercise in health and disease. The first 
study investigated how the cardiovascular system supplies O2-rich blood to the active 
muscle during exercise. The second study examined the influence of alterations in 
skeletal muscle mitochondrial O2 consumption on exercise tolerance in patients with 
COPD. Finally, the third study investigated whether O2 supply or O2 demand limit 
VO2max in untrained and endurance exercise-trained individuals.
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The Role of the Cardiovascular System in Supplying 
O2-Rich Blood to Active Muscle 
At the onset of dynamic exercise there is a dramatic increase in demand for O2 by 
the exercising muscle. To meet this demand, the cardiovascular system must increase 
blood flow to the exercising muscle from 5 to >80% of maximum cardiac output (Rowell, 
1992; Laughlin, 1999). As there is a finite cardiac output, this large demand for blood 
flow can only be achieved by diverting blood away from other organs. Therefore, at the 
onset of exercise, acting through both feed-forward (i.e., central command) and rapid 
feedback mechanisms (e.g., baroreceptors), the cardiovascular system initiates a systemic 
sympathetically-mediated vasoconstriction response to redirect the limited blood supply 
away from inactive organs and towards the active muscle where perfusion is now needed 
(Fadel, 2013; Mitchell, 2013). As the sympathetic vasoconstrictor response is systemic 
in nature, even the vasculature feeding the exercising muscle receives the signal to 
vasoconstrict, which if left without opposition would result in decreased blood flow and 
O2 delivery to the active muscle. In healthy subjects this systemic vasoconstrictor 
response is met with opposition within the active muscle which, a phenomenon known as 
functional sympatholysis (Remensnyder et al., 1962), facilitates localized vasodilation in 
the face of the systemic vasoconstrictor response.
As impaired functional sympatholysis can result in malperfusion, insufficient O2 
supply to the muscle and exercise intolerance, uncovering the factors that mediate 
sympatholysis has been the subject of many investigations (Hansen et al., 2000; Kirby et 
al., 2008; Mortensen et al., 2012; Saltin & Mortensen, 2012). At this point it appears that 
byproducts of the metabolism occurring in the muscle are largely responsible for this
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response and are thought to elicit vasodilation by stimulating smooth muscle 
hyperpolarization and nitric oxide and/or prostanoid release (Hansen et al., 2000; 
Sarelius & Pohl, 2010). However, which metabolic byproducts are responsible for 
initiating sympatholysis is still unclear. Recently, considerable attention has been 
focused upon adenosine and ATP found within the muscle interstitial fluid as their 
presence has been reported to attenuate sympathetically-mediated vasoconstriction. 
(Mortensen et al., 2009a; Mortensen et al., 2009b). Other putative metabolic effectors of 
functional sympatholysis include K+, H+, and radiating heat (Hansen et al., 2000; Sarelius 
& Pohl, 2010).
As one of the most abundant byproducts o f relatively inefficient mitochondrial 
metabolism, heat has attracted significant attention as a potential mediator of 
sympatholysis. In vitro experiments using isolated arteries have been useful in 
investigating the effect of heat on vascular function (Kluess et al., 2005; Ives et al., 2011; 
Ives et al., 2012a). Using isolated human skeletal muscle feed arteries, Ives et al. (2011; 
2012a) reported that the vasocontractile response to the a 1 adrenergic agonist, 
phenylephrine (PE), was attenuated in an NO-dependent manner when the arteries were 
heated to temperatures similar to those experienced by the muscle during exercise (39°C). 
While it is clear that the sympatholytic effect observed by Ives et al. (2011; 2012a) was 
mediated by endothelial nitric oxide synthase (eNOS) (Ives et al., 2012a), it is unclear 
what actually senses the heat and initiates this response. Thus, the first study of this 
dissertation examined the mechanisms involved in sensing and mediating this 
sympatholytic effect of heat in isolated human skeletal muscle feed arteries.
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Skeletal Muscle Mitochondrial Respiratory Function 
and O2 Demand in Exercise 
Mitochondria, ubiquitous organelles, act as the terminal consumer of the O2 
supplied by the cardiopulmonary system in the O2 cascade. These organelles, which 
weave throughout a cell in the form of a reticulum, serve many important functions, the 
most notable of these functions being ATP resynthesis via oxidative phosphorylation 
(Hatefi, 1985). In the process of oxidative phosphorylation, O2 reduction (i.e., O2 
consumption) is coupled with the phosphorylation of ADP to form ATP. In this process, 
illustrated in Figure 1.1, hydrogen ions are funneled down a chemiosmotic gradient from 
the intermembrane space across the inner membrane into the mitochondrial matrix 
through a molecular complex and enzyme, known as ATP synthase. The flow of 
hydrogen ions through ATP synthase causes a conformational change in the protein, 
which provides the energy for the combination of ADP with inorganic phosphate to form 
ATP. The deposition of hydrogen ions into the intermembrane space is facilitated by 
energy released by the movement of electrons from Complex I (CI) to IV (CIV) of the 
electron transport chain (ETC) which, in turn, is dependent on the availability of O2 at 
CIV to accept these electrons. Without O2 to accept these electrons, oxidative 
phosphorylation cannot occur (Hatefi, 1985).
Independent of changes in mitochondrial density, qualitative alterations in the 
intrinsic function of the mitochondria can also impact mitochondrial ATP resynthesizing 
capacity and efficiency. For example, as electrons entering the ETC at CII are at a lower 
energy state than those entering at CI, O2-consumption driven by CII results in the 
resynthesis of fewer ATP than O2-consumption driven by CI (Lee et al., 1996).
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Consequently, a greater amount of O2 is required for CII-driven respiration to 
resynthesize the same amount of ATP as CI-driven respiration. Intrinsic mitochondrial 
function may also be affected by uncoupling the relationship between O2 consumption 
and ATP resynthesis. Contrary to the simplified mitochondrion illustrated in Figure 1.1, 
not all hydrogen ions are funneled down the gradient through ATP synthase. Some of the 
hydrogen ions may bypass ATP synthase by leaking through the membrane and others 
may achieve this by traveling through other channels, such as uncoupling proteins or the 
ADP/ANT translocase (Gnaiger, 2009; Larsen et al., 2011; Pesta & Gnaiger, 2012). 
Mitochondrial O2 consumption not coupled to ATP synthesis during in vitro experiments 
is termed State 2 respiration (Pesta & Gnaiger, 2012). Similar to altering the 
contributions of CI and CII, altering coupling or State 2 respiration can impact the 
function of the mitochondria, with greater uncoupling leading to a greater O2 cost of ATP 
resynthesis (Hinkle, 2005).
Given the role mitochondria play in fueling muscular work during endurance 
exercise, it is not surprising that alterations in mitochondrial respiratory function have 
been suggested to play a role in the exercise intolerance exhibited by several patient 
populations, including patients with COPD (Picard et al., 2008a; Naimi et al., 2011; 
Meyer et al., 2013). In addition to exhibiting severely impaired pulmonary function, 
patients with COPD also exhibit debilitating exercise intolerance, which is thought to be 
related to an increased O2-cost of physical activity (Richardson et al., 2004; Man et al., 
2009; Medeiros et al., 2014). Indeed, diminished mitochondrial respiratory capacity 
related to reduced mitochondrial density likely plays a role in the exercise intolerance 
exhibited by patients with COPD (Picard et al., 2008a; Bronstad et al., 2012). However, a
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mere reduction in the amount of mitochondria present in the muscle cannot account for 
the increased O2-cost of exercise that accompanies the disease, suggesting that qualitative 
alterations in the mitochondria may also play a role in COPD. Therefore, the second 
study of this dissertation investigated the possibility that qualitative alterations in 
mitochondrial respiration contribute to the exercise intolerance exhibited by 
patients with COPD.
Mitochondrial O2 Supply and Demand during Exercise 
During incremental, dynamic exercise the rate of O2 consumption (VO2) increases 
proportionally to workload until reaching a point, known as VO2max, where VO2 fails to 
increase despite further increases in workload. While VO2 can be described as the 
product of O2 supply (QO2) to the mitochondria and O2 demand by the mitochondria 
(VO2=QO2 x Extraction), it is unclear whether O2 supply and/or O2 demand limit VO2max. 
Some have hypothesized that the capacity of the cardiopulmonary system to supply O2 to 
the mitochondria and the capacity of the mitochondria to consume O2 are tightly 
matched, such that the capacity of neither is in excess at VO2max (Hoppeler & Weibel, 
1998). Alternatively, some have hypothesized that O2 supply strongly limits VO2max, 
such that the mitochondria are in excess at VO2max (Levine, 2008; Boushel et al., 2011; 
Boushel & Saltin, 2013). Still others have hypothesized that mitochondrial O2 demand 
limits or determines VO2max (Cardus et al., 1998). Therefore the role of O2 supply and O2 
demand in determining VO2max is currently unclear.
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O2 Supply and O2 Demand as determinants of VO2max 
Based on the concept that physiological systems are designed to match function, it 
has been postulated that all of the parts of the O2 cascade are expressed in strict 
proportion to the task required of them at VO2max, such that no component (e.g., O2 
supply or O2 demand) is in excess or deficient compared to others at VO2max (Taylor & 
Weibel, 1981; Weibel et al., 1991; Hoppeler & Weibel, 1998). This hypothesis, often 
referred to as the theory of symmorphosis, is supported by the tight, linear relationship 
between mitochondrial volume and VO2max across many mammalian species (Weibel et 
al., 1991; Hoppeler & Weibel, 1998). However, while a given increase in mitochondrial 
volume is typically associated with a predictable increase in VO2max for most mammalian 
species, the VO2max achieved by humans is often less than predicted based upon 
mitochondrial volume (Hoppeler & Weibel, 1998), which challenges the concept of 
symmorphosis in humans. Indeed, the application of this theory to humans is further 
called into question by the disproportionally small increase in VO2max compared to the 
relatively large increase in mitochondrial capacity that typically accompanies endurance 
training (Gollnick et al., 1973; Jacobs & Lundby, 2013). Therefore, while this theory of 
economic design appears to apply well to many species (Hoppeler & Weibel, 1998), it 
does not appear to completely describe the O2 cascade in humans.
O2 Supply to the Mitochondria and VO2max
Some have concluded that O2 supply limits mitochondrial O2 consumption and 
subsequently VO2max (Levine, 2008; Boushel et al., 2011; Boushel & Saltin, 2013). 
Much of the evidence supporting this position comes from experiments operating under 
the premise that if O2 supply acts as a bottleneck along the O2 cascade, increasing O2
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9supply should increase VO2max. Indeed, multiple studies, most using physically active or 
endurance-trained subjects, have reported that increasing O2 supply by having subjects 
breath hyperoxic gas increases VO2max during maximal exercise by approximately 10% 
(Margaria et al., 1972; Ekblom et al., 1975; Knight et al., 1993). Similarly, augmenting 
O2 supply to the mitochondria by increasing the concentration of hemoglobin (Hb) in the 
blood has also been reported to augment VO2max (Joyner, 2003). Based upon the high 
proportion of cardiac output that is distributed to the exercising muscle (Secher et al., 
1977) and upon comparisons between recreationally active and elite endurance-trained 
athletes (Levine, 2008), it has been suggested that the source of the O2 limitation starts 
centrally with a limited cardiac output (Levine, 2008). Thus, it appears that O2 supply 
limits mitochondrial respiratory capacity to some extent in some populations, including 
endurance-trained athletes.
Two general approaches have been used to quantify the extent to which O2 supply 
suppresses mitochondrial respiratory capacity at VO2max. The first method compares 
mass-specific VO2max during large-muscle mass exercise to small-muscle mass exercise, 
during which central factors such as cardiac output are not likely to be limiting 
(Richardson & Saltin, 1998). Indeed, the mass-specific O2 supply and VO2max reported 
during KE (KEVO2max) are nearly double that reported for cycling exercise 
(CyclingVO2max) (Richardson, 2003), which suggests that the mitochondria are only 
operating at half-capacity at VO2max during large muscle exercise.
The second method utilized to determine the extent to which O2 supply suppresses 
mitochondrial respiration at VO2max compares the mass-specific VO2max during a given 
exercise to the mass-specific VO2max of biopsied muscle fibers measured in vitro
(MitoVO2max) (Rasmussen et al., 2001; Boushel et al., 2011). Utilizing such an approach, 
Boushel et al. (2011) reported that CyclingVO2max was about 36% lower than MitoVO2max, 
further supporting the idea that mitochondrial O2 consumption is markedly limited by O2 
supply. If the mitochondria are so severely limited by O2 supply, it seems unlikely that 
any decrement in mitochondrial function, such as those observed in patients with COPD 
(Picard et al., 2008a), would have any effect on exercise capacity as there would be a 
substantial amount of reserve capacity to buffer any such decrement in mitochondrial 
function. However, in this regard, it should be noted that the amount of reserve capacity 
reported by such studies (Richardson, 2003; Boushel et al., 2011) may be somewhat 
exaggerated as absolute rates of O2 consumption are commonly normalized by the entire 
lower-limb muscle mass, which is unlikely to be fully recruited during cycling (Lollgen 
et al., 1980; Green & Patla, 1992).
O2 Demand by the Mitochondria and VO2max
While many studies support the concept of an O2-supply limitation at VO2max, not 
all studies support such a position. Interestingly, studies that provide evidence of an O2- 
demand limitation appear to be most common among untrained or sedentary subjects. 
For example, breathing hyperoxic gas, which augmented the VO2max of trained subjects 
(Ekblom et al., 1975; Knight et al., 1993), had no effect on the VO2max during cycling in 
sedentary adults (Cardus et al., 1998). Additionally, following 2 weeks of exercise 
training, the training-induced gain in VO2max of previously sedentary subjects was related 
to increased mitochondrial O2 demand and not delivery (Jacobs et al., 2013). Indeed, 
Roca et al. (1992) reported that prior to endurance training, sedentary subjects were 
insensitive to hypoxia, whereas after training these same subjects exhibited a reduction in
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exercise capacity in hypoxia. Thus, it is seems possible that physical activity, which has 
been reported to have disproportionate effects on mitochondrial capacity and VO2max 
(Gollnick et al., 1973), may result in a shift in the limitation to VO2max, away from O2 
demand toward O2 supply. Consequently, the purpose of the third study of this 
dissertation was to determine if O2 supply and O2 demand similarly limit VO2max in 
untrained and endurance-trained subjects by comparing these variables, in vitro, 
during maximal exercise with maximal in vitro mitochondrial O2 consumption.
Summary of Specific Aims of Dissertation 
As the O2 cascade plays a critical role in determining health and physical 
function, alterations in how this cascade supplies or demands O2 may have significant 
consequences in terms of health and quality of life. Advancing a greater understanding 
of the regulation and factors associated with O2 supply and demand, and how disease may 
affect these processes, is necessary for developing therapies and treatments for those with 
dysfunctional O2 transport and utilization. Therefore, this dissertation will address the 
following specific aims:
1. Determine the mechanisms involved in sensing and mediating the sympatholytic 
effect of heat in isolated human skeletal muscle feed arteries
2. Investigate the possibility that qualitative alterations in skeletal muscle 
mitochondrial O2 consumption contribute to exercise intolerance exhibited by 
patients with COPD
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Figure 1.1: Mitochondrial electron transport chain and oxidative phosphorylation
Electrons are delivered to Complex I and Complex II in the form of NADH and FADH2, 
which are then passed on to coenzyme Q (Q), which transports the electrons on to 
Complex III. From Complex III, the electrons are shuttled to Complex IV by cytochrome 
c (C). It is at Complex IV where oxygen (O2) is reduced (i.e., consumed) by the electrons 
to form water. Note that as the electrons are passed from complex to complex energy is 
released. At Complexes I, III, and IV this energy is used to shuttle hydrogen ions (H+) 
across the inner membrane into the intermembrane space. The hydrogen ions are then 
funneled back across the inner membrane through ATP synthase, providing the energy 
for the resynthesis of ATP from adenosine diphosphate (ADP) and inorganic phosphate 
(Pi). See Hatefi, 1985 for a more detailed description of the electron transport chain and 
oxidative phosphorylation.
CHAPTER 2
a1 AND a2 ADRENERGIC RESPONSIVENESS IN HUMAN SKELETAL 
MUSCLE FEED ARTERIES :THE ROLE OF TRPV ION CHANNELS 
IN HEAT-INDUCED SYMPATHOLYSIS
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on- and 012-Adrenergic responsiveness in human skeletal muscle feed 
arteries: the role of TRPV ion channels in heat-induced sympatholy­
sis. Am J Physiol Heart Circ Physiol 307: H1288-H1297, 2014. First 
published August 29, 2014; doi:10.1152/ajpheart.00068.2014.—The 
purpose of this study was to determine if heat inhibits 012-adrenergic 
vasocontraction, similarly to oii-adrenergic contraction, in isolated 
human skeletal muscle feed arteries (SMFA) and elucidate the role of 
the temperature-sensitive vanilloid-type transient receptor potential 
(TRPV) ion channels in this response. Isolated SMFA from 37 
subjects were studied using wire myography. oti [Phenylephrine 
(PE)]- and ct2  [dexmedetomidine (DEX)]-contractions were induced 
at 37 and 39°C with and without TRPV family and TRPV4-specific 
inhibition [ruthenium red (RR) and RN-1734, respectively]. Endothe­
lial function [acetylcholine (ACh)] and smooth muscle function [so­
dium nitroprusside (SNP) and potassium chloride (KC1)] were also 
assessed under these conditions. Heat and TRPV inhibition was 
further examined in endothelium-denuded arteries. Contraction data 
are reported as a percentage of maximal contraction elicited by 100 
mM KC1 (LTmax). DEX elicited a small and variable contractile 
response, one-fifth the magnitude of PE, which was not as clearly 
attenuated when heated from 37 to 39°C (12 ± 4 to 6 ± 2% LTma,; 
P = 0.18) as were PE-induced contractions (59 ± 5 to 24 ± 4% 
LTmax; P < 0.05). Both forms of TRPV inhibition restored PE- 
induced contraction at 39°C (P < 0.05) implicating these channels, 
particularly the TRPV4 channels, in the heat-induced attenuation of 
oii-adrenergic vasocontraction. TRPV inhibition significantly blunted 
ACh relaxation while denudation prevented heat-induced sympatho­
lysis without having an additive effect when combined with TRPV 
inhibition. In conclusion, physiological increases in temperature elicit 
a sympatholysis-like inhibition of ai-adrenergic vasocontraction in 
human SMFA that appears to be mediated by endothelial TRPV4 ion 
channels.
heat; feed arteries; alpha adrenergic; sympatholysis; TRPV ion chan­
nels
d u r i n g  m u s c le  c o n t r a c t i o n ,  the normal vasoconstriction re­
sponse to stimulation of a i-  and oi2 -adrenoceptors is attenuated 
in a process termed functional sympatholysis (4, 25). Inspired 
by the theory that exercise-induced heat generation plays a role 
in mediating this local inhibition of a-adrenergic vasoconstric-
Address for reprint requests and other correspondence: R. S. Richardson, 
VA Medical Center Bldg 2, 500 Foothill Dr., Salt Lake City, UT 84148 
(e-mail: r.richardson@hsc.utah.edu).
tion (4), our group recently tested the effect of heat on a i- 
adrenergic responsiveness in isolated human skeletal muscle 
feed arteries (SMFA) (14,15). In 2011, Ives et al. (15) reported 
that simply heating these isolated feed arteries from 37 to 39°C 
(approximate temperature of muscle at rest and exercise, re­
spectively; Ref. 28) attenuated ai-induced adrenergic vasocon­
traction by ~40%. It was later determined that this sympatho­
lytic effect of heat could be prevented by inhibiting endothelial 
nitric oxide synthase (eNOS) (14), implicating nitric oxide 
(NO) as a key player in heat-induced sympatholysis. While 
these studies support the concept of heat-induced sympatholy­
sis, they do not explain how these denervated arteries sense the 
increase in temperature to initiate the relaxing response.
Within the endothelial and smooth muscle cells of the 
vasculature exists a family of temperature-sensitive ion chan­
nels, known as the vanilloid-type transient receptor potential 
(TRPV) ion channels, which seems poised to serve as the link 
between heat exposure and sympatholysis. In fact, while in­
vestigating the function of type IV TRPV (TRPV4) ion chan­
nels Watanabe et al. (36) reported that heating cultured cells, 
including mouse aorta endothelial cells, to temperatures similar 
to those employed by Ives et al. (14, 15) resulted in an influx 
of calcium that was prevented by treating cells with the TRPV 
antagonist ruthenium red (RR) or by the genetic inhibition of 
the TRPV4 channels specifically. Considerable additional ev­
idence indicates that the activation of the TRPV ion channels 
by other stimuli, like shear stress and endogenous ligands, can 
modulate vascular responsiveness and enhance endothelial- 
dependent dilation (2,7, 8 ,19,21,24,35,39). Therefore, given 
their known impact on vascular function and sensitivity to 
physiological temperatures (2, 6, 33), it seems plausible that 
the TRPV ion channels, especially TRPV4 ion channels, play 
a role in sensing and mediating the sympatholytic effect of heat 
in human SMFA (14, 15). However, this potential mechanism 
has yet to be elucidated.
Therefore, the purpose of this study was to better character­
ize ct-adrenergic function in human SMFA and explore the 
possibility that the TRPV ion channels, particularly the TRPV4 
channel, act as the link between elevated temperature and 
blunted 01-adrenergic vasocontraction (14, 15). As the function 
of the 012-adrenoceptors, which has yet to be documented in 
these arteries, is believed to differ from their ai-counterparts in 
distribution and sensitivity to sympatholysis (18, 23), we first 
sought to compare the effects of oti- and oi2-agonists on human 
SMFA and determine whether 012-induced vasocontraction is
H1288 http://www.ajpheart.org
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also inhibited in the heat. We then tested two hypotheses 
regarding the role of TRPV ion channels in the restoration of 
vascular function mediated by oti- and ct2 -adrenoceptors in the 
heat. Specifically, based on the observation of Watanabe et al. 
(36) that TRPV inhibition prevented the response of cultured 
endothelial cells to heat, we first hypothesized that the inhibi­
tion of these ion channels and/or endothelial denudation would 
result in the restoration of a-adrenergic vasocontraction at 
39°C to levels observed at 37°C. Second, we tested the hy­
pothesis that this restorative effect of TRPV inhibition would 
be associated with altered endothelial function and not altered 
smooth muscle function.
METHODS
Subjects and General Procedures
Thirty-seven diverse subjects (22 male, 15 female, 22-71 yr) under­
going routine melanoma-diagnosis-related surgery donated SMFA that 
were removed during the normal course of the surgery. Vessels from 
subjects who had undergone chemotherapy were not included in this 
study as this was a contraindication for the surgery. Other medical 
conditions and medications used by the subjects were noted, but no 
exclusion criteria were based on these data (Table 1). All protocols 
used in this study were approved by the Institutional Review Board of 
the University of Utah and Salt Lake City Veterans Affairs Medical 
Center, and informed written consent was obtained from all subjects 
before surgery. All protocols were carried out in accordance with the 
Declaration of Helsinki.
Vessel Harvest and Preparation
SMFAs from the axillary and inguinal regions were obtained 
during melanoma-related node dissection surgeries at the Huntsman 
Cancer Hospital and the Salt Lake City Veterans Affairs Hospital.
Table 1. Subject characteristics
Means ± SE Normal Range
Vital characteristics
Age 53 ± 2 —
Male/female (n) 22/15 —
Height, cm 175 ± 2 —
Weight, kg 88 ± 3 —
Body mass index, kg/m2 28 ±  1 —
Systolic blood pressure, mmHg 128 ± 3 —
Diastolic blood pressure, mmHg 78 ± 2 —
Mean arterial blood pressure, mmHg 94 ± 2 —
Blood and plasma
Glucose, mg/dl 96 ± 3 65-110
Blood urea nitrogen, mg/dl 16 ±  1 6-21
Creatinine, mg/dl 1.0 ±  0.1 0.52-0.99
Lactate dehydrogenase, U/l 317 ±  28 313-618
Hemoglobin, g/dl 14 ±  0.3 12-16
White blood cells, X l03/jxl 7 ± 0 .3 3.6-10.6
Red blood cells, X106/p l 4.7 ±  0.1 4.0-5.2
Platelets, X103/^il 244 ±  12 150-400
Hematocrit, % 43 ±  1 36—46
Cardiovascular medication (users/n)
Diuretic 3/37 —
Ca2+ channel blocker 3/37 —
(3-Blocker 2/37 —
Angiotensin blocker 1/37 —






Patients were anaesthetized using a standard protocol including 
propofol, fentanyl, benzodiazepines, and succinylcholine. After 
lymph node dissection, feed arteries entering muscles in the axillary 
(e.g., serratus anterior, or latissimus dorsi) or inguinal (e.g., quadri­
ceps femoris or hip adductors) regions were identified and classified 
as SMFA based on entry into a muscle bed, structure, blood color, and 
pulsatile bleed pattern. The vessels were ligated, excised, and then 
immediately placed in cold (~4°C), normal physiological saline 
solution (NPSS), which consisted of 125 mM NaCl, 4.7 mM KC1,1.2 
mM KH2P04, 1.2 mM MgS04, 2.5 mM CaCl2, 18 mM NaHC03, 
0.026 mM Na2EDTA, and 11.2 mM glucose. Note that the pH of the 
NPSS in the bath was maintained at 7.4 ± 0.5 at all temperatures 
throughout the entirety of the experiment. Vessels were then brought 
to the laboratory for experimentation within 15 min of harvesting.
Once at the laboratory, feed arteries were dissected (to remove all 
perivascular adipose and other tissue) under a stereomicroscope and 
cut into six to eight ring segments (~2 mm in length) while immersed 
in cold NPSS. Rings were then mounted in wire myography chambers 
(700 MO; DMT Systems, Aarhus, Denmark) in cold NPSS that was 
continuously aerated with carbogen gas (95% 0 2-5% C02) through­
out the experiment. The diameter and length of the mounted rings 
were assessed using a calibrated micrometer eyepiece. Myography 
chambers were then gradually warmed to a baseline temperature of 
37°C during a 30-min equilibration period before beginning the 
protocol. During the protocol, NPSS was exchanged every 15 min 
except during the concentration-response curves described below.
Vessel Function Protocols
Before the administration of TRPV inhibitors all artery segments 
underwent a length-tension protocol (15) at 37°C to assure that the 
arteries were at the length (Lmax) that would elicit the greatest 
contractile response to a single exposure to 100 mM KC1 dissolved in 
NPSS (LTmax). Specifically, LT^a* was reached when increasing the 
length of the arteries increased the response to 100 mM KC1 by <  10% 
(15). Following the length tension protocol, half of the rings were 
continuously incubated with a TRPV antagonist to assess the role of 
the TRPV ion channels in modulating the responsiveness of the 
arteries. Given that multiple TRPV ion channels may potentially be 
involved in mediating the sympatholytic effect of heat, RR (30 jxM) 
(29), a nonspecific TRPV antagonist (6, 29), was applied to the 
arteries to inhibit the activity of the family of TRPV channels. As the 
TRPV4 ion channel has been reported to be activated by similar levels of 
heat, as utilized in this study, previously in arterial preparations (36), the 
selective TRPV4 antagonist RN-1734 (20 jxM) (3, 34) was applied to 
a different set of arteries (n = 7) to explore the role of this specific ion 
channel in the sympatholytic effect of heat.
After allowing the treated rings to incubate in RR or RN-1734 for 
15-20 min, a-adrenergic responsiveness of all rings (TRPV inhibited 
and control rings) was assessed at 37°C by generating concentration- 
response curves to the ai-agonist phenylephrine (PE; 10-9-10-3 
logM) and the a2-agonist dexmedetomidine (DEX; 10-lo-10-3 
logM). Due to the variability of individual vessel ring caliber, vaso- 
contractile responses for each ring were normalized to the maximum 
response to 100 mM KC1 during the length tension protocol (i.e., 
LTmax) (15). As described previously (14), the endothelium-depen­
dent vasorelaxation was assessed with concentration-response curves 
to acetylcholine (ACh; 10_7-10“3 logM) following preconstriction 
with PE to —70% of the maximum PE response. Note that the order 
of the PE and DEX concentration-response curves was alternated in a 
balanced manner to account for any ordering effect.
The chambers were then heated from 37 to 39°C over a period of 
10 min. After a 20- to 30-min equilibration period, the concentration- 
response curves for PE, DEX, and ACh were performed once again as 
described above. As prior exposure to heat has been reported to alter 
adrenergic responsiveness (27) we, like others (15, 20), always per­
formed the highest temperature phase last. Given the potential for a
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00068.2014 • www.ajpheart.org
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time effect in this design, we performed a time control experiment in 
a set of six arteries by generating concentration-response curves to PE 
(10-9-10-3 logM), with the temperature held constant at 37°C at hour 
1 and hour 2 of the experiment in the presence and absence of RR.
As previous research has suggested that the sympatholytic effect of 
heat may be mediated by the endothelium (14), we also sought to 
determine whether the effect of the TRPV ion channels on vascular 
function was endothelium dependent by performing the control and 
RR experiments in endothelium denuded arteries (« — 6). Arteries 
were denuded by passing 2 ml of air through the lumen of the artery 
before it was dissected and mounted on the wire myograph (22). Once 
mounted, denudation was verified by the vessel rings exhibiting 
<10% relaxation to ACh (10-3) at 37°C.
Another set of arteries was used to assess the effect of heat and 
TRPV inhibition on smooth muscle function. Following the length 
tension protocol described earlier, rings were rinsed with NPSS and 
allowed to recover to baseline tension. To test receptor-independent 
smooth muscle vasocontraction with and without TRPV inhibition, 
KC1 was added to the NPSS buffer at 37 and 39°C to progressively 
raise the concentration of KC1 in the bath from 10 to 100 pM, with 
and without RR. Endothelium-independent relaxation was assessed 
with concentration-response curves to the NO donor sodium nitro- 
prusside (SNP; 10-9-10-4 logM) in all conditions (37 and 39°C with 
and without RR) following preconstriction with PE. As pilot studies 
suggested that prior exposure to SNP may alter vascular responsive­
ness, each ring used in the SNP protocol was exposed to only one of 
the four conditions (37 or 39°C, with or without RR).
Statistical Analyses
All myography tension data were acquired at 4 Hz with an analog- 
to-digital data acquisition system (Biopac Systems, Goleta, CA). As 
described above, unless otherwise stated, contraction data are repre­
sented as a percentage of the maximum contraction elicited by 100 
mM KC1 during the length tension protocol (i.e., %LTma„) for each 
arterial ring, and relaxation data are represented as the magnitude of 
relaxation from preconstriction tension divided by the magnitude of 
preconstriction tension for each arterial ring (i.e., %relaxation). As the 
arterial rings do not always reach peak relaxation or tension at the 
highest drug concentration, maximum relaxation and contraction data, 
regardless of concentration, are presented in addition to the concen- 
tration-response curve data. Sensitivity of the arteries to PE, DEX, 
KC1, and SNP was assessed by calculating the logECso with a 
sigmoidal parameter {(a + b — a)/[ 1 + 10u c)]} as described 
previously (15).
Statistical analyses were performed using SPSS statistical software 
(SPSS version 17; SPSS, Chicago, IL), while graphs and figures were 
created using Sigma Plot version 11 (Systat Software, San Jose, CA). 
Note that values presented in text and figures are means ± SE, unless 
otherwise stated. Repeated-measures ANOVA followed by Tukey’s 
post hoc test was used to determine if ai- and c*2-stimulation resulted 
in significant contractions above baseline levels. A paired t-test was 
used to examine differences between maximal on- and ot2-induced 
vasocontraction. Repeated-measures ANOVA followed by Tukey’s 
post hoc test was used to examine the effect of temperature and TRPV 
inhibition and denudation on arterial responsiveness for each concen­
tration-response curve, maximum response, and logECso- The level of 
significance for all tests was set a priori at a  = 0.05.
RESULTS
Vessel Characteristics
Twenty-seven SMFA from the axillary region and ten 
SMFA from the inguinal region were harvested for this study. 
The average internal diameter of the feed arteries was 515 ± 
40 n,m. The maximum response to the length tension protocol
(LTmax) was 1,076 ±  135 mg at Lmax, with a starting tension 
of 1,254 ±  82 mg.
Vessel Function
ai- and ot2 -Adrenergic responsiveness. At 37°C, exposure to 
the ai-agonist PE and the ot2 agonist DEX resulted in signif­
icant contractions above baseline tension (P <  0.05), with 
higher concentrations of DEX tending to elicit relaxation from 
the tension generated in response to lower concentrations of 
DEX (Fig. 1). Interestingly, responsiveness to DEX proved to 
be more varied from artery to artery with many arteries 
exhibiting little-to-no response to DEX while several others 
exhibited strong responses to DEX (—45% LTmax). This vari­
ance was not accounted for by age nor gender, although 
females did tend to have a greater response to DEX than males 
(17 ±  6 and 8 ±  3, respectively, P = 0.18). Nevertheless, Fig. 
1 illustrates that on average the magnitude of maximal a.2 - 
induced contractions was far less than the magnitude of the 
maximal oti-induced contractions (59 ±  5 and 12 ±  4% LTm,.. 
respectively; P  <  0.001).
Effect o f TRPV inhibition and heat on ot-adrenergic 
function. Treating arteries with RR or RN-1734 had no signif­
icant effect on baseline tension at 37°C (P >  0.05). Heating 
human SMFA from 37 to 39°C resulted in a small, yet 
significant, increase in baseline tension (35 ±  15 mg; P < 
0.05). While statistically significant, it should be noted that this 
change in basal tension only represents an increase equivalent 
to 3% LTmax. Interestingly, inhibition of the TRPV ion chan­
nels prevented the heat-related increase in baseline tension 
such that no significant change in basal tone was observed 
when heated in the presence of RR (—8 ±  6 mg; P  >  0.05).
As illustrated in Fig. 1, ai-adrenergic responsiveness, as 
assessed by concentration-response curves with PE, was sig­
nificantly attenuated at 39°C (24 ±  4% LTm„ )  compared with 
the 37°C control condition (P <  0.05). 012-Adrenergic contrac­
tion with DEX also exhibited a similar tendency for decreased 
vasocontraction when comparing 37 to 39°C (12 ±  4, 6 ±  2% 
LTmax), but due to the already recognized variability in the 
responses, this heat-induced sympatholysis did not reach sta­
tistical significance (P = 0.18). As hypothesized, treating 
arteries with RR restored oti-adrenergic contraction at 39°C to 
levels observed under the 37°C control condition, such that 
there was no significant difference between the 37CC control 
response curve and the 39°C RR curve (P >  0.05) or maximum 
contraction elicited by the drugs (PE: 48 ±  7% LTmax, and 
DEX: 14 ±  3% hT mal respectively; P  >  0.05). Similarly, no 
evidence of heat-induced sympatholysis of a-adrenergic vaso­
contraction at 39°C was observed in arteries treated with 
RN-1734 (65 ±  11% L T ^ ;  Fig. 1, C and D).
To determine if the restorative effect of RR and RN-1734 on 
the heat-induced attenuation of cn-adrenergic vasocontraction 
was due to the blocking of the sympatholytic effect of heat or 
if it was acting through some other mechanism, we also 
examined the effect of the drugs on adrenergic responsiveness 
of the arterial rings at 37°C (Fig. 1). Initially, due to a tendency 
that failed to reach statistical significance, it appeared that PE- 
and DEX-induced vasocontraction may be potentiated by 
TRPV inhibition at 37°C, but, despite raising the n to increase 
statistical power, no significant effect of RR on PE- or DEX- 
induced vasocontraction at 37°C was observed (P >  0.30). It
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Fig. 1. Effect of temperature with and without vanilloid-type transient receptor potential (TRPV) family and TRPV4-specilic inhibition [ruthenium red (RR) and 
RN-1734, respectively] on a i [phenylephrine (PE)]- and 012 [dexmedetomidine (DEX)]-induced adrenergic vasocontraction. A: effect of temperature and RR on 
PE concentration-response curve. B: effect of temperature and RR on DEX concentration-response curve. C: effect of temperature and RN-1734 on PE 
concentration-response curve. D: effect of temperature and RN-1734 on DEX concentration-response curve. ^Response to concentration significantly different 
than same concentration in the 37°C control condition (P <  0.05). tConcentration-response curve significantly different than 37°C control curve (P <  0.05).
should also be noted that neither temperature nor treatment 
with RR or RN-1734 elicited significant differences between 
any other pairings besides those including the 39°C control 
condition and did not significantly alter the sensitivity of the 
arteries (i.e., logECso), which averaged —4.9 ± 0 .1  logM for 
PE and -7 .3  ±  0.2 logM for DEX.
Effect o f heat and TRPV inhibition on endothelial function. 
As illustrated in Fig. 2A, heating from 37 to 39°C tended to 
augment but ultimately had no significant effect on endothelial- 
dependent relaxation induced by exposure to ACh (maximum 
relaxation: 65 ±  5 and 75 ±  8%, respectively; P  >  0.05) while 
the application of RR significantly and strongly attenuated
ACh-induced vasorelaxation compared with control condition 
at both 37 and 39°C (P <  0.05). It is worth noting that 
relaxation in the presence of RR was similarly blunted at 37 
and 39°C such that no significant difference between the two 
conditions was observed (maximal relaxation: 38 ±  4 and 
32 ±  5%; P  >  0.05). As illustrated in Fig. 2B, inhibition of the 
TRPV4 channels with RN-1734 yielded a similar significant 
attenuation of ACh-induced dilation at 37°C (20 ±  8% relax­
ation) and 39°C (17 ±  7% relaxation). As TRPV inhibition 
appeared to affect endothelial function, ACh-induced dilation 
with RR was tested in endothelial-denuded arteries (Fig. 2, C 
and D). There was no significant difference in ACh-induced
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Fig. 2. Effect of heating with and without TRPV family and TRPV4-specific inhibition (RR and RN-1734, respectively) on endothelium-dependent, 
acetylcholine-induced (ACh) vasorelaxation. A: effect of heat and RR on ACh concentration-response curve. B: effect of heat and RN-1734 on ACh 
concentration-response curve. C: effect of heat, RR, and endothelial denudation on ACh concentration-response curve. D: effect of heat, RR, and endothelial 
denudation on ACh concentration-response curve. *Response to concentration significantly different than the same concentration in the 37°C control condition 
(P <  0.05). f  Concentration-response curve significantly different than 37°C control curve (P < 0.05).
dilation between endothelial-denuded arteries with or without 
RR.
Like TRPV inhibition, endothelial denudation prevented the 
sympatholytic effect of heat on ai-adrenergic contraction (Fig. 
3A; P  >  0.05). Furthermore, no additive effect of TRPV 
inhibition was revealed in endothelium-denuded arteries sug­
gesting that the effect of the TRPV ion channels in this 
response is largely endothelially mediated. Endothelial denu­
dation with or without RR had no statistically discernible effect 
on a 2-adrenergic contraction at 37 or 39°C (Fig. 3, B  and D). 
Additionally, it should be noted that neither temperature nor 
treatment with RR or RN-1734 elicited significant differences
between any other pairings besides those including the control 
condition.
Effect o f heat and TRPV inhibition on smooth muscle 
function. Figure 4 illustrates that receptor-independent vaso- 
contraction (KC1) was unaffected by heating from 37 to 39°C 
(maximum contraction: 94 ±  5 and 97 ±  6% LTmax respec­
tively; P >  0.05). Additionally, the inhibition of the TRPV 
channels with RR did not significantly alter KCl-induced 
contraction at 37°C (maximum contraction: 95 ±  4% LTm„: 
P >  0.05) or 39°C (maximum contraction: 95 ±  6% LTm„.: 
P > 0.05). Neither heat nor TRPV inhibition significantly 
altered the sensitivity of the arteries to KC1 (EC50 = 34 ±  3
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Fig. 3. Effect of endothelial denudation and TRPV family ion channel inhibition (RR) on heat-induced sympatholysis of a i  (PE) and az [dexmedetomidine 
(DEX)] adrenergic vasocontraction. A\ effect of temperature and endothelial denudation on the PE concentration-response curve. B: effect of temperature and 
endothelial denudation on the DEX concentration-response curve. C: effect of temperature and nonspecific TRPV inhibition (RR) with endothelial denudation 
on the PE concentration-response curve. D: effect of temperature and nonspecific TRPV inhibition (RR) with endothelial denudation on the DEX 
concentration-response curve. *Response to concentration significantly different than same concentration in the 37°C control condition (P <  0.05). 
tConcentration-response curve significantly different than 37°C control curve (P <  0.05).
mM). Likewise, neither temperature nor RR significantly af­
fected endothelium-independent relaxation as assessed by cu­
mulative exposures to SNP (P >  0.05). Finally, as illustrated in 
Fig. 5, time had no significant effect on PE-induced vasocon­
traction (P >  0.05).
DISCUSSION
In this study we sought to better characterize a-adrenergic 
function in human SMFA and determine if the temperature- 
sensitive TRPV ion channels act as the mechanistic link be­
tween elevated temperature and attenuated a-adrenergic re­
sponsiveness in these arteries. This study resulted in three 
novel observations. First, we described the relative roles of the 
a i-  and <X2-adrenoceptors in human SMFA and documented 
that a 2-mediated vasocontraction is not as clearly inhibited by 
heat as ai-mediated vasocontraction. Second, we observed that 
inhibiting the TRPV ion channels, particularly the TRPV4 
channel, results in the restoration of ai-adrenergic vasocon­
traction at 39°C, thereby implicating this channel in the sym­
patholytic effect of heat. Third, we determined that heat-
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response curves with both a i-  and 012-agonists (PE and DEX, 
respectively) to determine what contribution the oi2-receptors 
make at the level of the feed artery. Indeed, the stimulation of 
a 2-adrenoceptors resulted in significant vasocontraction above 
baseline; however, the magnitude of responsiveness varied 
dramatically from artery to artery with some exhibiting little- 
to-no response to DEX and others exhibiting robust responses 
on the order of —45% LTmax. Additionally, among many 
subjects higher concentrations of DEX (>10-4 M) tended to 
result in relaxation and not constriction, as observed at the 
lower concentrations. The reason for this large variability is 
unclear but may possibly be related to the heterogeneity among
Fig. 4. Effect of heating and TRPV ion channel inhibition (RR) on smooth 
muscle function. A: effect of heat and RR on endothelium-independent vaso­
contraction [potassium chloride (KC1)] concentration-response curve. B: effect 
of heating and RR on endothelial independent vasorelaxation [sodium nitro- 
prusside (SNP)] concentration-response curve.
induced sympatholysis, and the role of the TRPV ion channels 
in this phenomenon, occur in an endothelium-dependent man­
ner.
Characterization ai- and ct2 -Vasocontraction in Human 
SMFA
Others have reported that the contribution of a 2-mediated 
constriction is greater in distal resistance arterioles than in 
proximal conduit arteries (38). With the feed artery lying 
somewhere between the proximal conduit and distal resistance 
arteries (16, 17, 30), the role of the <X2-receptors in human 
SMFA is unknown. Therefore, we performed concentration-
Fig. 5. Effect of time on a i  (PE)-induced arterial responsiveness with and 
without TRPV family inhibition (RR). A: effect of time on concentration- 
response curve to PE with and without RR. B: effect of time on maximum 
response to PE with and without RR.
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subjects participating in this study who varied considerably in 
terms of sex, age, and health history (31). Despite the variabil­
ity of responses, on average the magnitude of the maximum 
012-induced contraction was relatively small, amounting to 
approximately only 20% of the magnitude of maximum a i- 
induced vasocontraction (Fig. 1 ,A  and B). It is possible that the 
in vitro isolation itself may have diminished the responsiveness 
of the oi2-adrenoreceptors as others have reported that in vitro 
isolation of arteries decreases a 2-adrenergic contraction by 
~60% (13). However, it is important to note that even if our in 
vitro response was 40% of what would be observed in vivo, the 
corrected maximal 012-adrenergic contraction would still 
amount to only 45% of its ai-counterpart. Therefore, our data 
indicate that the a 2-adrenoceptor plays less of a role than the 
a  1-adrenoceptor in regulating the diameter and tone of human 
SMFA.
Much controversy exists as to the extent to which each 
a-receptor subtype is inhibited under sympatholytic condi­
tions. Several studies have reported that ai-adrenoceptors are 
insensitive or less sensitive to sympatholysis than their a 2- 
counterparts (1, 5, 32, 38) while others have reported that both 
a-subtypes are equally sensitive to sympatholysis (26). As 
illustrated in Fig. 1, both a i- and 012-induced vasocontraction 
tended to be inhibited when heated to 39°C, but only cti- 
induced contraction was significantly inhibited by the heat. At 
first glance it seems that the (X 2 -recep tors  are not sensitive to 
heat-induced sympatholysis as they were not significantly 
inhibited at 39°C; however, upon further examination the 
tendency for heat-induced sympatholysis is evident in the 
012-induced contraction (Fig. 1, B and D). Thus it seems 
possible that the lack of a significant attenuation of 012-induced 
vasocontraction may be more related to the relatively small and 
varied vasocontraction associated with 012-induced contractions 
rather than a lack of sensitivity to heat. Further research is 
needed to determine if these adrenoceptors do, in fact, differ in 
terms of sensitivity to heat. Additionally, the varied nature of 
the DEX response may have also obscured the effect of other 
conditions like TRPV inhibition and denudation on 012-induced 
vasocontraction, which revealed no clear trends.
Role o f TRPV Channels in Heat-induced Sympatholysis o f 
Adrenergic Vasocontraction
Given their known temperature sensitivity (2, 6, 11, 21, 36) 
and interaction with vascular function ranging from coronary 
to cutaneous circulation (7, 10, 21, 37, 40), we hypothesized 
that the TRPV ion channels would serve as the link between 
elevated temperature and attenuated a-adrenergic contraction 
in isolated human SMFA. Indeed, as illustrated in Fig. 1 A, the 
inhibition of the TRPV ion channel family with RR restored 
ai-adrenergic vasocontraction at 39°C to levels observed at 
37°C implying that the TRPV ion channels play a role in 
mediating heat-induced sympatholysis. Such inhibition had no 
significant effect on a 2-adrenergic vasocontraction (Fig. IB). 
Having observed that nonspecific TRPV inhibition restored 
ai-adrenergic contraction in the heat, we sought to determine 
if a single member of the TRPV family could be implicated in 
this response. Given their sensitivity to temperatures ranging 
from 25 to 39+°C (2) and their previously described relation­
ship with endothelium-dependent dilation (21, 41), we ex­
plored the possibility that the TRPV4 ion channel mediates the
H1295
sympatholytic effect of heat. As illustrated in Fig. 1C, similar 
to arteries treated with nonspecific TRPV inhibition, arteries 
treated with the TRPV4-specific inhibitor RN-1734 exhibited 
normal levels of vasocontraction in the face of the heat stim­
ulus. Thus these data indicate that the TRPV4 ion channel is 
specifically involved in mediating the sympatholytic effect of 
heat, which is in agreement with previous research that has 
documented that heating cultured rat aortic endothelial cells 
elicits an intracellular calcium flux that was prevented by 
inhibiting the TRPV4 channels (36). Thus it appears that the 
TRPV4 ion channel senses, either directly or indirectly (2, 36), 
the increase in temperature and subsequently initiates the 
sympatholytic effect of heat. Interestingly, although TRPV 
inhibition at 37°C tended to augment adrenergic contraction in 
some cases, this did not do occur consistently or significantly 
suggesting that the TRPV channels have only a minor influence 
on a i-  and a 2-induced vasocontraction under seemingly nor- 
mothermic conditions.
Potential Mechanisms o f Involvement o f TRPV Channels in 
Heat-Induced Sympatholysis
As we have previously determined that heat-induced sym­
patholysis is the result of increased NO production (14), it 
seems likely that the activation of the TRPV4 ion channels 
with heat attenuates adrenergic vasocontraction by precipitat­
ing an increase in endothelial NO production. The likelihood of 
this potential explanation is supported by several lines of 
evidence. Using isolated endothelial cells and arteries from 
rats, Kohler et al. (21) found that applying moderate warmth 
(~37°C) increased the activity of the TRPV4 ion channels and 
reported that such an increase in activity did in fact augment 
NO-dependent vasodilation. Furthermore, the putative rela­
tionship between TRPV activation and NO production is sup­
ported by reports that the activation of TRPV1 ion channels 
increases eNOS activity and NO production in isolated skeletal 
muscle arterioles and endothelial cells (7, 19).
Although we did not measure NO production in the current 
study, we did probe the role of the endothelium in this phe­
nomenon by assessing endothelial-dependent vasorelaxation 
with ACh and examining the effect of heat on endothelium- 
denuded arteries. As illustrated in Fig. 2, when the TRPV ion 
channels were inhibited, with RR or RN-1734, ACh-induced 
relaxation was potently attenuated thereby supporting the re­
lationship between the TRPV channels and die endothelium 
that has been reported previously (21). If the TRPV channels in 
the endothelium initiated that sympatholytic effect of heat, it 
stands to reason that one would find augmented ACh-induced 
vasorelaxation in the heated condition. Interestingly, although 
such a tendency existed, we did not observe a significant 
potentiation of ACh-induced relaxation, possibly due to the 
heterogeneity among subjects. Nevertheless, more concrete 
evidence that the TRPV ion channels mediate the sympatho­
lytic effect of heat in an endothelium-dependent maimer comes 
from the current experiments that indicated that the endothe­
lium is vital for the sympatholytic effect of heat. Specifically, 
that TRPV inhibition in conjunction with endothelial denuda­
tion had no additive effect on the response to PE in denuded 
arteries (Fig. 3). Considering that denudation prevented the 
sympatholytic effect of heat, and that TRPV inhibition atten­
uated endothelium-dependent relaxation while preventing the
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sympatholytic effect of heat, it seems likely that the TRPV4 
ion channels mediate the response in an endothelium-depen­
dent manner and not by way of altered smooth muscle func­
tion, which was not significantly affected by heat and TRPV 
inhibition (Fig. 4).
It is worth noting that, like eNOS inhibition (14), denudation 
had no significant effect on a i-  or a 2-vasocontraction at 37°C 
indicating that endothelial activity does not significantly sup­
press adrenergic contraction under normothermic conditions. 
Additionally, it is important to note that the arteries in this 
preparation were studied in isolation, thus precluding a role of 
the central nervous system in the sympatholytic effect of heat. 
Nevertheless, it should be noted that even with careful dissec­
tion it is likely impossible to completely remove all nerve 
fibers from the SMFA and therefore there remains the possi­
bility that TRPV ion channels on sensory and/or sympathetic 
nerve endings embedded in the artery wall mediate the vascular 
response in a manner similar to the axon reflex that mediates 
cutaneous hyperemia in response to local heating (12, 37).
Experimental Considerations
As prior exposure to heat has been reported to alter adren­
ergic responsiveness (27), we, like others (15, 20), performed 
the highest temperature phase last. Recognizing that with this 
design the observed decreases in adrenergic responsiveness 
may be due to time and not temperature, we performed a time 
control experiment with PE in SMFA. As illustrated in Fig. 5, 
and in agreement with prior work (15), adrenergic vasocon­
traction was preserved over the duration of the experiment 
indicating that time was likely not a factor in the decreased 
adrenergic responsiveness we observed with heating. Due to 
the limited supply of human SMFA we limited the time control 
experiment to PE-induced contractions reasoning that if time 
had an effect on adrenergic contraction it would likely affect 
PE-induced and DEX-induced contraction similarly.
Based on previous research (36), we hypothesized that the 
TRPV4 ion channel would mediate the sympatholytic response 
to heat, but given the potential overlap in temperature sensi­
tivity by other members of the TRPV family we could not rule 
out the possibility that other TRPV ion channels were involved 
in mediating the response. Therefore, we used the chemical 
RR, a nonspecific TRPV ion channel inhibitor, to screen for the 
role of the TRPV family in the sympatholytic effect of heat. 
Once the data using RR pointed to a role for TRPV ion 
channels, a more specific inhibitor, RN-1734, was utilized to 
pinpoint which TRPV channel was involved. With regard to 
RR it is important to consider that it is not completely specific 
to the TRPV ion channels and may affect other channels like 
the cold-sensitive TRPM8 channels, which are not likely to be 
active under the warm conditions of our experiment, and 
ryanodine receptors (8). Thus the possibility exists that these 
other channels may account, in part, for some of the results of 
this experiment. Nevertheless, the response to stimuli, like 
heat, by tissues treated with RR and by tissues in which the 
TRPV channels have been genetically nullified, document 
good agreement (9, 24, 36). Additionally, it should be noted 
that in the current study there was good agreement between the 
effects of RR and RN-1734 and there was no significant impact 
of RR on baseline tension, like in the work of Kohler et al. 
(21). Thus it appears that RR had the majority of its effects on
the heat-sensitive TRPV ion channels and not on other putative 
targets of the drug.
As documented in Table 1, the subjects participating in this 
study were heterogeneous in terms of age, sex, and health 
history and therefore do not reflect a specific subset of the 
population but rather represent humans as a whole. Further­
more, although the SMFA were harvested during sentinel node 
biopsies, performed to determine if melanoma has spread from 
the skin, this was of little significance as, in the majority of 
these cases, the cancer was determined not to have had sys­
temic consequences. Thus the conclusions of this study are 
likely applicable to the population as whole.
Conclusions
In this study we sought to describe the functional roles of a i- 
and oi2-adrenoceptors in SMFA and explore the possibility that 
the TRPV ion channels, particularly the TRPV4 channel, act as 
the link between elevated temperature and blunted ot-adrener- 
gic vasocontraction. We conclude that the contribution of the 
a 2-receptors in human SMFA is minimal, more varied, and not 
as clearly inhibited by heat compared with the ai-receptors. As 
hypothesized, the inhibition of TRPV ion channels, particularly 
the TRPV4 channels, restored a  i -adrenergic vasocontraction at 
39°C to levels observed at 37°C, thereby implicating the TRPV 
ion channels as a component of the heat-induced sympatholysis 
acting in an endothelial-dependent manner. Thus it appears that 
physiological increases in temperature, typical of the muscle 
bed during moderate intensity exercise, likely activate the 
endothelial TRPV4 ion channels to modulate vascular func­
tion, ultimately yielding a sympatholysis-like attenuation of 
a-adrenergic vasocontraction.
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EXERCISE INTOLERANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE 




This study sought to determine if qualitative alterations in skeletal muscle 
mitochondrial respiration, associated with decreased mitochondrial efficiency, contribute 
to exercise intolerance in patients with COPD. Using permeabilized muscle fibers from 
the vastus lateralis of 13 patients with COPD and 12 healthy controls, Complex I (CI) and 
Complex II (CII)-driven State 3 mitochondrial respiration were measured separately 
(State 3:CI and State 3:CII) and in combination (State 3:CI+CII). State 2 respiration was 
also measured. Exercise tolerance was assessed by knee extensor exercise (KE) time to 
fatigue. Per mg of muscle, State 3:CI+CII and State 3:CI were reduced in COPD 
(P<0.05), while State 3:CII and State 2 were not different between groups. To determine 
if this altered pattern of respiration represented qualitative changes in mitochondrial 
function, respiration states were examined as percentages of peak respiration (State 
3:CI+CII), which revealed altered contributions from State 3:CI (Con: 83.7 ± 3.4 COPD:
72.1 ± 2.4 %Peak, P<0.05) and State 3:CII (Con: 64.9± 3.2 COPD: 79.5 ± 3.0 %Peak, 
P<0.05) respiration, but not State 2 respiration in COPD. Importantly, a diminished 
contribution of CI-driven respiration relative to the metabolically less-efficient CII-driven 
respiration (CI/CII) was also observed in COPD (Con: 1.28 ± 0.09, COPD: 0.81 ± 0.05, 
P<0.05), which was related to exercise tolerance of the patients (r=0.64, P<0.05). 
Overall, this study indicates that COPD is associated with qualitative alterations in 
skeletal muscle mitochondria that affect the contribution of CI and CII-driven respiration, 
which potentially contributes to the exercise intolerance associated with this disease.
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Introduction
Exercise intolerance and an increased oxygen (O2)-cost of physical activity are 
common features of COPD and are related to diminished quality of life and increased 
mortality in this population (Richardson et al., 2004; Man et al., 2009; Medeiros et al., 
2014). While impaired lung function certainly plays a role in exercise intolerance, the 
fact that diminished physical function persists even after lung function is restored by 
transplantation or other therapeutic means (Lands et al., 1999; Amann et al., 2010; 
Bartels et al., 2011) indicates that mechanisms peripheral to the pulmonary system are 
involved in this dysfunction. Impaired mechanical efficiency (i.e., increased ATP or O2 
cost of contraction) has been documented in the exercising muscle of patients with COPD 
(Baarends et al., 1997; Richardson et al., 2004; Medeiros et al., 2014) and is thought to 
contribute to this debilitation. However, the underlying mechanisms involved in this 
decreased mechanical efficiency and their relationship to exercise intolerance in COPD 
remain uncertain.
During exercise, mechanical efficiency is influenced by both the efficiency of the 
mitochondria to resynthesize ATP (i.e., mitochondrial efficiency) and the efficiency of 
the muscle to translate ATP into mechanical work (i.e., ATP cost of contraction) (Whipp 
& Wasserman, 1969). Our group recently reported that patients with COPD exhibit an 
increased ATP cost of muscle contraction which likely contributes to diminished 
mechanical efficiency (Layec et al., 2011; Layec et al., 2012). However, mitochondrial 
efficiency, which can be influenced by either an alteration in the relative contributions of 
CI and CII- driven respiration in the electron transport chain (ETC) or an uncoupling of
O2 consumption from ATP synthesis (i.e., non-phosphorylating respiration), was not
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investigated in this previous work (Layec et al., 2011; Layec et al., 2012). Indeed, either 
or both of these scenarios of mitochondrial inefficiency could potentially play a role in 
the decreased mechanical efficiency and exercise intolerance observed in patients with 
COPD, but neither have been thoroughly investigated.
A shift in the contributions of CI and CII-driven respiration to peak respiration 
can affect mitochondrial efficiency, because electrons entering the ETC at CI, in the form 
of NADH, are at a higher energy state and subsequently result in the translocation of 
more protons than those entering at CII in the form of FADH2. Thus, the FADH2-derived 
electrons ultimately yield fewer ATP per O2 consumed (i.e., a lower P/O ratioj than their 
NADH-derived counterparts (Lee et al., 1996). Therefore, a decreased contribution of CI- 
driven respiration in favor of a greater contribution of CII-driven respiration to overall 
respiration may result in a greater O2 cost for a given workload, and potentially result in 
exercise intolerance. Furthermore, uncoupled O2 consumption by the ETC occurs when 
hydrogen ions, pumped across the mitochondrial innermembrane in an O2-dependent 
manner, bypass ATP synthase and pass down the proton gradient by other means (e.g., 
uncoupling proteins), resulting in non-phosphorylating O2 consumption or proton leak 
(Brand & Esteves, 2005). Currently, the extent to which uncoupled respiration is present 
in the skeletal muscle of patients with COPD is unclear. Indeed, the studies that have 
examined this facet of mitochondrial respiration in COPD have produced conflicting 
results reporting either exaggerated or unchanged uncoupling in COPD (Rabinovich et 
al., 2007; Picard et al., 2008b; Naimi et al., 2011). Although these phenomena may 
contribute to the increased O2 cost of exercise recognized in patients with COPD (Picard 
et al., 2008; Bronstad et al., 2012) and ultimately negatively impact exercise tolerance,
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this hypothesis has not been extensively tested in this population.
Therefore, the purpose of this study was to determine if qualitative alterations in 
skeletal muscle mitochondrial respiration play a role in the exercise intolerance 
associated with COPD. Specifically, we hypothesized that, compared with healthy 
controls, patients with COPD would exhibit decreased mitochondrial efficiency with 
reduced utilization of CI-driven respiration relative to CII-driven respiration as well as 
increased uncoupling (State 2 respiration) and that this decreased mitochondrial 
efficiency may contribute to exercise intolerance during KE in the patients with COPD.
Methods
Subjects
Thirteen patients with moderate-to-severe COPD and thirteen age-matched, 
healthy controls were recruited for this study based on spirometric evidence of airway 
obstruction (FEV1 <80% predicted, FEV/FVC<0.70), or the lack thereof (FEV1 >80% 
predicted, FEV1/FVC>0.70), respectively. These determinations were achieved by 
standard pulmonary function tests (Celli et al., 2004). Thigh volume and muscle mass 
were assessed by a series of circumference and skin fold thickness measurements of the 
upper leg, as previously described (Layec et al., 2014). Resting arterial O2 (SaO2) 
saturation was assessed with a pulse oximeter (Nellcor N-595, Pleasanton, CA, USA) 
placed on the tip of the middle finger following 5 minutes of seated rest. All patients 
and controls completed the study with the exception of one control who withdrew for 
reasons unrelated to the study. The Institutional Review Boards at the University of Utah 
and the Salt Lake City VA Medical Center approved all protocols employed in this study.
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Accordingly, all subjects provided written informed consent before inclusion in this 
study.
Muscle Biopsy
Subjects reported to the laboratory for the muscle biopsy having refrained from 
vigorous exercise for 24 hours. A muscle sample of the vastus lateralis muscle was 
obtained by a percutaneous needle biopsy 15 cm proximal to the knee at a depth of 3.5 
cm under sterile conditions (Richardson et al., 2004). Immediately after the muscle 
sample (~150 mg) was taken from the leg, part of the sample (~30 mg) was immersed in 
ice-cold biopsy preservation fluid (BIOPS) for respiratory analyses (Pesta & Gnaiger, 
2012), while the remaining sample was immediately frozen and stored at -80°C for later 
histological and biochemical analysis.
Mitochondrial Respiration and Histochemical Analyses
Muscle samples were prepared and permeabilized for mitochondrial respiration 
analysis as described by Pesta et al. (2012). Briefly, BIOPS-immersed fibers were 
carefully separated with fine-tip forceps and subsequently bathed in a BIOPS-based 
saponin solution (50^g saponin/ml BIOPS) for 30 minutes. Following saponin treatment, 
muscle fibers were rinsed twice in ice-cold mitochondrial respiration fluid (MIR05) for 
10 minutes each rinse. After rinsing for a total of 20 minutes, fibers were blotted with a 
paper towel to measure the weight of each sample (2-4 mg).
Muscle fibers were then placed in the temperature-controlled respiration chamber 
(Oxytherm, Hansatech Instruments. Norfolk, UK) in 2 ml MIR05 solution and warmed 
to 37°C. After allowing the muscle fibers 10 minutes to equilibrate, mitochondrial
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respiratory function was assessed using the protocol described in Table 3.1 to determine 
the peak CI-driven respiration (State 3:CI), the peak CII-driven respiration (State 3:CII), 
and the peak CI+CII-driven respiration (State 3:CI+CII). O2 consumption not linked to 
phosphorylation (i.e., State 2) was also assessed (Table 3.1). Importantly, all fibers 
included in this study exhibited evidence of mitochondrial membrane integrity (less than 
a 10% increase in respiration in response to cytochrome c). Initially, respiration data 
were examined in terms of O2 flux per mg of tissue (wet weight) to obtain an indication 
of mitochondrial capacity per milligram of tissue. To further explore whether the 
mitochondria of patients with COPD exhibit qualitative changes in mitochondrial 
respiratory function, respiration was also examined in terms of flux control ratios (Pesta 
& Gnaiger, 2012). These internal ratios, which juxtapose one respiration state to another 
within an experimental run, provide insight into the qualitative function of the 
mitochondria in a mitochondrial content-independent manner (Pesta & Gnaiger, 2012). 
Muscle fiber type (Myosin Heavy Chain I and II) cross-sectional area, proportion and 
capillarity were assessed on frozen muscle samples by immunohistochemistry and 
morphometry using the methods described by Bloemberg et al. (2012).
Dynamic Single Leg Knee Extensor Exercise 
Dynamic single leg KE exercise was performed on a custom-made KE ergometer 
(Andersen et al., 1985; Richardson et al., 1993). After undergoing several familiarization 
visits, subjects performed exercise protocols to determine both maximum KE work rate 
(i.e., power) and endurance/exercise tolerance. Maximum KE work rate was determined 
with subject-specific incremental protocols (2-5 watts per minute) designed to reach a 
point of exhaustion within 8-12 minutes (Richardson et al., 1995). KE endurance or
exercise tolerance was determined by having subjects perform KE at 80% of their 
maximum work rate until exhaustion (Rossman et al., 2013). In both KE tests, subjects 
were instructed to maintain a cadence of 60 rpm until exhaustion. Exhaustion or task 
failure was defined as the inability to maintain a cadence of greater than 50 rpm.
Assessment of Physical Activity 
Physical activity was assessed over the course of 7-10 days via accelerometry 
(Actigraph LLc, Pensacola Fl), which has recently been validated for use in COPD 
patients (Rabinovich et al., 2013). These accelerometers, which assess physical activity 
in counts by summing the accelerations along three axes over the course of each minute, 
were worn by subjects during all waking hours, except when showering or swimming. 
Based on the recommendations of the manufacturer of the accelerometer, thresholds for 
sedentary, light, and moderate to vigorous activity were defined as <99, 100-1959, and 
1952+ counts/min, respectively. Gait speed represents the usual walking speed (average 
of two trials) of the subjects over 10 meters (Schmid et al., 2007).
Statistical Methods
Differences in respiration states were analyzed with two-way repeated measures 
ANOVA. Significant main effects or interactions were subsequently analyzed with 
Holm-Sidak post hoc test. Differences in subject characteristics between groups were 
made with independent samples t tests. Correlations between variables were assessed 





As represented in Table 3.2, patients and controls were of similar age and BMI. 
However, by design, spirometric indices of lung function were decreased in the patients 
with COPD (P<0.05). Nevertheless, resting O2 saturation was similar between groups. 
KE maximum work rate was not different between groups, however, KE endurance was 
greatly reduced in the patients with COPD (P<0.05). Although all subjects underwent the 
biopsy procedure and completed all other testing, two of the patients with COPD failed to 
complete the KE protocols, for reasons unrelated to the study. Interestingly, there were no 
differences in fiber type or capillary density between the patients with COPD and the 
controls (P>0.05). Gait speed and physical activity, assessed by both accelerometry and 
steps per day, were lower in the patients with COPD than the healthy controls (P<0.05). 
Eleven of the thirteen patients with COPD were former smokers and reported an average 
time elapsed since quitting of 13 ± 3 years (range 2-28 years). Four of the controls were 
identified as former smokers and reported an average time elapsed since quitting of 39 ±
6 years (range of 22-60 years). One patient with COPD and none of the controls reported 
being current smokers. Aside from the medications subjects were free of any 
medications within the last 6 months.
Mitochondrial Respiration and Muscle Characteristics 
In terms of respiration per mg of muscle, a significant interaction existed between 
subject group (i.e., Control or COPD) and respiration states (P<0.05), such that the 
impact of COPD on respiration depended on the respiration state under consideration. 
Notably, State 3: CI (37.9 ± 2.7 and 23.9 ± 2.3 pMol/mg/s, P<0.05) and State 3:CI+CII
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(46.5 ± 3.8 and 33.8 ± 3.8 pMol/mg/s, P<0.05) were both lower in patients with COPD 
(P<0.05), while State 3:CII (29.0 ± 2.3 and 26.8 ± 2.8 pMol/mg/s , P>0.05) was similar 
between groups. State 2 respiration, when expressed in terms of respiration per mg of 
muscle, was not significantly different between controls and patients (14.2 ± 1.5 and 9.0 
± 1.3 pMol/mg/s, P=0.18).
As wet weight muscle respiration indicated altered utilization of the CI and CII 
pathways in COPD, the relative contribution of each pathway in terms of percent of peak 
respiration during State 3:CI+CII (Figure 3.1B) was explored. Consistent with the data 
represented in terms of wet weight respiration (Figure 3.1A), a significant interaction 
between subject group and respiration state was observed (P<0.05). Further analysis 
revealed a diminished contribution of the CI pathway in COPD (83.7 ± 3.4 and 72.1 ± 2.4 
% Peak, P<0.05) and further revealed an exaggerated contribution of the CII pathway 
(64.9± 3.2 and 79.5 ± 3.0 % Peak, P<0.05). State 2 respiration represented as a 
percentage of peak respiration was not different between groups (33.5 ± 4.1 and 32.3 ±
4.5 % Peak, P<0.05).
As it was hypothesized that patients would exhibit a greater reliance on CII-driven 
respiration than CI-driven respiration, additional analysis of the relative contribution of 
the CI- and CII-driven pathways with the CI/CII was performed. As illustrated in Figure 
3.2A, CI/CII was significantly lower in patients with COPD compared to controls (0.82 ± 
0.05 and 1.27± 0.05 respectively; P<0.05).
Mitochondrial Respiration, KE Endurance, and Lung Function 
To explore the implications of this altered mitochondrial phenotype on exercise 
tolerance, the relationship between CI/CII and KE endurance (i.e., time to exhaustion)
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was examined (Figure 3.2B). Overall, CI/CII exhibited a significant relationship with KE 
endurance (r=0.43, P<0.05), which appears to have been driven largely by the moderate 
correlation within the patients (r=0.64, P<0.05), as no relationship was found when only 
the healthy controls were included in the correlation analysis (r=0.03; P=0.94). Lung 
function, as assessed by FEV1, also exhibited a significant inverse relationship with 
CI/CII (r=0.55, P<0.05), with those subjects with a lower FEV 1 demonstrating a 
decreased utilization of the CI-driven pathway.
Discussion
The purpose of this study was to determine if qualitative alterations in skeletal 
muscle mitochondrial respiration are associated with exercise intolerance in patients with 
COPD. In terms of intrinsic mitochondrial function, patients with COPD exhibited a 
decreased reliance on CI-driven respiration and a greater reliance on the metabolically 
less-efficient CII-driven respiration, while uncoupled respiration was not different 
between groups. As detailed below, this study provides novel evidence that the exercise 
intolerance exhibited by patients with COPD is related to qualitative alterations in 
skeletal muscle mitochondrial respiratory function.
CI vs. CII-Driven Respiration in COPD 
As already recognized, the exercise intolerance exhibited by patients with COPD 
is thought to be partly related to changes within the muscle that result in an increased O2 
cost of exercise (Richardson et al., 2004; Medeiros et al., 2014). Indeed, as has been 
reported previously (Picard et al., 2008b; Naimi et al., 2011; Bronstad et al., 2012), in the 
current study muscle fibers from patients with COPD exhibited significantly reduced
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rates of respiration per mg of muscle (Figure 3.1A). Certainly these reduced rates of O2 
consumption may impair aerobic capacity, especially when coupled with the reduced 
muscle mass sometimes exhibited by patients with COPD (Table 3.2). However, such 
attenuated respiration rates do not necessarily confer a qualitative change in the 
mitochondrial function that could explain the increased O2-cost of exercise associated 
with COPD (Picard et al., 2008b). Given that electrons entering the ETC at CII require 
more O2 to resynthesize a given amount of ATP than electrons entering at CI (Lee et al., 
1996), we hypothesized that, patients with COPD would also exhibit an increased 
reliance on the less-efficient CII-driven respiration compared to the more-efficient CI- 
driven respiration. Indeed, such a pattern of altered respiration was evident in patients 
with COPD, as State 3:CI was significantly reduced in COPD compared to controls while 
State 3:CII was not (Figure 3.1). Thus, in agreement with previous research (Bronstad et 
al., 2012), it appears that the reduction in State 3:CI+CII exhibited by patients with 
COPD in the current study was largely driven by diminished CI-driven respiration rather 
than CII-driven respiration. (Figure 3.1A). Consequently, when considered in relative 
terms, the current data indicate that CI-driven respiration makes up a lesser proportion of 
peak respiration and provides a smaller metabolic contribution than CII-driven respiration 
in patients with COPD than in healthy controls (Fig. 3.1B, 3.2A).
In light of decreased CI-driven respiration, the maintenance of CII-driven 
respiration per mg tissue in the patients with COPD likely prevented further loss of 
respiratory function in the muscle that would have occurred if CII-driven respiration was 
also decreased. However, it should be emphasized that in terms of ATP production, CI 
and CII-driven respiration are not equal. Even if CII-driven respiration was exaggerated
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to the point that it to fully compensate for the diminished CI-driven respiration in terms 
of O2 consumption, given the lower P/O ratio, such augmented CII-driven respiration 
would not fully offset the decrement in terms of ATP production (Lee et al., 1996; 
Hinkle, 2005). Therefore, if  patients with COPD do rely on this less-efficient metabolic 
pathway more than controls, the mitochondria of the patients would be obligated to 
respire more than their healthy counterparts to produce the same amount of ATP. This 
appears to have been the case for the patients studied by Richardson et al. (Richardson et 
al., 2004) and Medeiros et al. (Medeiros et al., 2014) who demanded greater amounts of 
O2 to perform the same amount of work as their healthy counterparts. To date the P/O 
ratio from combined CI + CII driven respiration has not been fully explored in COPD. 
Previously, Puente-Maestu et al. (Puente-Maestu et al., 2009) reported that the P/O ratio 
of mitochondria from patients with COPD was similar to healthy controls, but in this case 
the P/O ratio was only measured during CII-driven respiration. Based upon our data, the 
P/O ratio is more likely to be depressed when both CI and CII are stimulated 
simultaneously, as it may be the relative contribution of each pathway during 
physiological respiration and not necessarily the isolated function of each pathway that 
affects the P/O ratio in patients with COPD. While it is not clear if  the qualitative 
alterations in mitochondrial respiration (i.e., reduced CI/CII) observed in the current 
study were associated with a decreased P/O ratio, it is clear that this altered respiratory 
profile was related to exercise intolerance among the patients, as those who exhibited low 
CI/CII (i.e., low contribution of CI with high contribution of CII) fatigued earlier than 
those patients who exhibited a greater CI/CII (Figure 3.2).
Currently, it is not clear why the mitochondria of patients with COPD exhibit
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diminished CI-driven respiration compared to the mitochondria of healthy controls. 
Interestingly, Daussin et al. (Daussin et al., 2008) reported a similar predominance of CII 
over CI-driven respiration in the mitochondria of sedentary individuals compared to those 
of endurance-trained individuals. In the current study, while both the patients and 
controls were relatively sedentary (Tudor-Locke & Bassett, 2004), the patients were less 
active than the controls (Table 3.2). Thus, it is possible that physical inactivity played a 
role in the diminished role of CI-driven respiration in COPD; however, it has previously 
been reported that altered mitochondrial respiration persists in patients with COPD even 
when matched for physical activity (Puente-Maestu et al., 2009). In this regard, it should 
be noted that the observed differences in respiration in the current study existed despite 
there being no significant difference in muscle fiber type (Table 3.2). Additionally, it has 
recently been suggested that the mitochondrial DNA of patients with COPD is highly 
susceptible to oxidative stress (Puente-Maestu et al., 2011; Konokhova et al., 2013). 
Interestingly, CII represents the only complex of the ETC that is not encoded, at least in 
part, by mitochondrial DNA. Thus, the shift in ETC pathway to predominantly CII- 
driven respiration may potentially be the consequence of decreased CI respiration due to 
mitochondrial DNA damage. Certainly, further research is needed to determine the role 
of physical activity and mitochondrial DNA integrity in the diminished utilization of CI- 
driven respiration observed in patients with COPD.
Uncoupled Respiration in COPD 
This study also tested the hypothesis that a component of the exercise intolerance 
typical of patients with COPD would be a consequence of an increase in uncoupled or 
non-phosphorylating O2 consumption. Contrary to our hypothesis, State 2 respiration per
mg of muscle was not significantly augmented among patients with COPD (Figure 3.1A); 
in fact, it tended to be lower among patients with COPD. Additionally, there was no 
difference in State 2 respiration when expressed as a percentage of peak respiration 
(Figure 3.1B). Thus, this trend appears to be the consequence of reduced peak respiration 
rather than a qualitative change within the mitochondria. Thus, based on these data, it 
seems unlikely that exaggerated uncoupled respiration contributes to the exercise 
intolerance or the increased O2-cost of exercise common to patients with COPD. 
Nevertheless, as noted earlier, evidence regarding uncoupled respiration in COPD is 
conflicting and somewhat complex. For example, Picard et al. (Picard et al., 2008b) 
reported no significant difference in State 2 respiration between patients with COPD and 
controls, while Naimi et al. (Naimi et al., 2011) reported that patients with COPD had 
significantly greater State 2 respiration than controls. As it has been demonstrated that 
cachexic patients with COPD are more likely to exhibit exaggerated uncoupling 
(Rabinovich et al., 2007), the disagreement between findings, may to some extent reflect 
the heterogeneity of disease severity among patients.
Increased O2 Cost of Contraction in an O2-Limited Population 
Based upon the current data, patients with COPD exhibit decreased mitochondrial 
efficiency in terms of CI/CII, but not in terms of uncoupling. When considered in 
isolation this decrease in mitochondrial efficiency may not appear to be a severe 
limitation in COPD, but when viewed in combination with other physiological alterations 
present in this patient population it becomes clear that this qualitative change in 
mitochondrial function has the potential to severely exacerbate exercise intolerance in 
COPD. First, it is worth noting that in patients with COPD O2 delivery is often reduced
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(Knower et al., 2001; Dempsey et al., 2006). For example, during exercise, particularly 
during large muscle mass exercise, patients with COPD exhibit varying degrees of 
pulmonary diffusion limitation that results in decreased blood O2 saturation and content, 
which may compromise muscle O2 delivery (Knower et al., 2001). Additionally, patients 
with COPD exhibit an increased work of breathing for a given level of exercise, which 
may limit locomotor muscle O2 delivery by redirecting a portion of a finite cardiac 
output, which may already exhibit a lower O2 content, away from the exercising 
locomotor muscles and toward the respiratory muscles (Dempsey et al., 2006). Thus, in 
patients with COPD, decreased mitochondrial efficiency may demand more O2 from an 
already reduced supply. Second, the consequences of decreased mitochondrial efficiency 
may be magnified by the increased ATP cost of contraction that our group recently 
observed in patients with COPD (Layec et al., 2011; Layec et al., 2012). Specifically, it 
appears that not only do patients with COPD utilize a less efficient ETC pathway to 
synthesize ATP, but once synthesized, more ATP is required to elicit a contraction cycle, 
thereby exaggerating the O2 cost of contraction even more. Third, given the decreased 
respiratory capacity per mg of muscle reported in this study (Figure 3.1A) and other 
studies (Picard et al., 2008b; Naimi et al., 2011; Bronstad et al., 2012), the ability of 
patients with COPD to meet the increased demand for O2 consumption due to altered 
mitochondrial efficiency is potentially hindered.
Together the multiple alterations in O2 supply by the cardiopulmonary system and 
O2 demand by the exercising muscle in patients with COPD likely converge to create a 
supply-demand mismatch where the exercising muscle demands more O2 to perform a 
given amount work and this is compounded by a diminished O2 supply. While it is
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unclear whether all of these factors converged in the current patients with COPD, it is 
evident that the documented reduction in mitochondrial efficiency was related to exercise 
intolerance (Figure 3.2B), thus implying that this phenomenon may play a role in the 
limited exercise capacity exhibited by these patients.
Conclusions
Qualitative alterations in skeletal muscle mitochondrial function that emphasize 
the relatively less efficient CII-driven respiration over the more-efficient CI-driven 
respiration appear to contribute to decreased muscle function and exercise intolerance in 
patients with COPD. As patients with COPD often experience compromised O2 supply, 
such an increase in metabolic demand may yield deleterious effects even during the 
relatively modest physical demands of performing simple activities of daily living.
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Table 3.1: M itochondrial Respiration Protocol: Description of the protocol used to 
assess mitochondrial respiratory function, and the site of action of each chemical 
introduced to the preparation (+ Substrate; -Inhibitor), and the respiration state associated 
with each step. Note that each step was approximately 3 minutes in duration.
Step # Chemical Name (concentration) Major Site of Action Respiration State
1 Malate (2mM), Glutamate (10mM) +Complex I (CI) State 2
2 ADP (5mM) +Complex V (CV) State 3: CI
3 Succinate (10mM) +Complex II (CII) State 3: CI+CII
4 Cytochrome C (10^M) Test of mitochondrial membrane integrity
5 Rotenone (0.5^M) -CI State 3: CII
Adenosine Diphosphate, ADP
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Table 3.2: Subject Characteristics
Controls COPD P
Subjects (female, male) 12  (2 f, 10m) 13 (3f, 10m)
Age (years) 69± 2 66 ± 2 0.36
BMI (kg/m2) 26±1 27 ± 2 0.73
Lung Function
FVC (Liters) 4.8 ± 0.3 3.2 ± 0.2* <0.001
FEV1 (Liters) 3.5± 0.2 1.7 ± 0.2 * <0.001
FEV1 (% Predicted) 119 ± 6 55 ± 5 * <0.001
FEV1/FVC (%) 79 ± 3 51 ± 4 * <0.001
Resting SaO2 (%) 95±1 94±1 0.57
Physical Activity and Function
Knee Extensor Max (watts) 29 ±4 24 ± 4 0.38
Knee Extensor Endurance
(mins)
14 ± 3 8 ± 1 * 0.04
Gait Speed (m/s) 1.38 ± 0.03 1 .12  ± 0.08* 0.007
Steps Per Day 5387±648 3067±250* 0.004





160±16 1 1 1 ± 1 0 0.14
Moderate-to-Vigorous 
Physical Activity (mins/day)
25 ± 4 8 ± 2 * 0.003
Muscle Characteristics
Quadriceps Muscle Mass (kg) 1.8 ± 0.1 1.4 ±0.1 0.06
Type 1 Fibers (%) 40±3 40±5 0.61
Type 2 Fibers (%) 60±3 60±5 0.61





0 7 * <0.001
Corticosteroid (n) 0 0 1.00
Statin-Type Drugs (n) 2 2 0.93
Muscle Relaxant (n) 0 2 0.14
Body Mass Index, BMI; Forced Vital Capacity, FVC; Forced Expiratory Volume in One Second, 
FEV1; Arterial Oxygen Saturation, SaO2; Number of Capillaries Around a Fiber, NCAF, 
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Figure 3.1: M itochondrial respiration of vastus lateralis muscle from patients with 
COPD and healthy controls. A.) Mitochondrial O2 flux per mg of muscle. B.) 
Mitochondrial respiration normalized to peak respiration observed during State 3 
















Figure 3.2: Relative contributions of Complex I and Complex II-driven respiration 
and knee extensor endurance A.) Ratio of State 3:CI to State 3:CII (CI/CII). B.) 
Relationship between CI/CII and knee extensor endurance. Note the significant 
relationship in the patients with COPD and lack of such a relationship in healthy controls. 
* Significantly different than healthy controls.
CHAPTER 4
SYMMORPHOSIS AND SKELETAL MUSCLE VO2MAX: IN VIVO AND 
IN VITRO MEASURES REVEAL DIFFERING CONSTRAINTS 
IN THE EXERCISE TRAINED AND UNTRAINED HUMAN
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Abstract
The hypothesis of symmorphosis postulates a quantitative match of structural and 
functional parameters within a defined system, but how this relates to oxygen (O2) supply 
and demand in determining maximal skeletal muscle O2 consumption (VO2max) in 
humans is unclear. Therefore, skeletal muscle VO2max was assessed in vitro (MitoVO2max, 
vastus lateralis permeabilized fibers) and in vivo during single leg knee extensor (KE) 
exercise (KEVO2max, direct Fick with femoral arterial blood flow (Doppler ultrasound) and 
arterial and venous blood samples) in 10 endurance-exercise trained and 10 untrained 
young males. Whole-body cycling VO2max (BodyVO2max, indirect calorimetry) was also 
measured. In the untrained subjects O2 delivery (462±37 ml/kg/min) during KE exercise 
exceeded MitoVO2max (364±16 ml/kg/min, P<0.05), which was not significantly different 
from KEVO2max (340±22 ml/kg/min, P>0.05). Conversely, in the trained subjects O2 
delivery during KE exercise (557±35 ml/kg/min) was significantly less than MitoVO2max 
(743±35 ml/kg/min, P<0.05) which, in turn, was significantly greater than KEVO2max 
(458±24 ml/kg/min). Additionally, while MitoVO2max in the untrained subjects was related 
to KEVO2max (r=0.69, P<0.05) and BodyVO2max (r=0.91, P<0.05), these variables were 
entirely unrelated in the trained subjects. Together these in vivo and in vitro measures 
reveal clearly differing determinants of VO2max in untrained and trained humans. 
Specifically, in the untrained, there is evidence against symmorphosis, with VO2max being 
determined by mitochondrial O2 demand. While, in contrast, trained subjects exhibit an 
exercise training-induced mitochondrial reserve that results in skeletal muscle VO2max, in 
vivo, being O2 supply limited, also not fitting the postulate o f  symmorphosis.
Introduction
VO2max, assessed during an incremental graded exercise test, is a strong predictor 
of mortality in both health and disease (Lee et al., 1999; Laukkanen et al., 2001; Kurl et 
al., 2003). However, despite the well-known predictive value of VO2max, it still remains 
unclear which step, if  any, along O2 cascade limits VO2max (Betik & Hepple, 2008). 
Based on a derivation of the Fick principle, VO2 is the product of muscle O2 delivery 
(QO2) and mitochondrial O2 extraction (VO2=QO2 x O2 extraction) (Richardson, 2003), 
and thus the steps of the O2 cascade that potentially determine VO2max can be generalized 
into two components: O2 supply to the skeletal muscle mitochondria by the 
cardiopulmonary system and O2 demand by the skeletal muscle mitochondria. Supported 
by the tight relationship between mitochondrial volume and VO2max across a broad range 
of mammalian species, proponents of the theory of symmorphosis have suggested that all 
steps of the O2 cascade are built in strict proportion to the task required of them at 
VO2max. Thus, neither the capacity for O2 supply nor the capacity for O2 demand would 
be in excess or limiting at VO2max (Hoppeler & Weibel, 1998). While this concept 
applies well when considering variation in VO2max across many species, how well 
symmorphosis pertains to humans is unclear as evidence and speculation from studies in 
humans consistently implicate distinct factors that may limit VO2max (Hoppeler & 
Weibel, 1998; Wagner, 2000; Levine, 2008).
While most agree that a rate-limiting step likely exists along the O2 cascade in 
humans, it is unclear whether the bottleneck is in the O2 supply to the mitochondria 
(Knight et al., 1992; Levine, 2008; Boushel et al., 2011) or O2 demand by the 
mitochondria (Roca et al., 1992; Cardus et al., 1998), and, subsequently, whether the
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capacity o f  either o f  these processes are actually in excess at VO2max. In a study o f 
similar design to the current work, Boushel et al. (4) attempted to shed light on this issue 
by comparing MitoVO2max in permeabilized muscle fibers to the mass-specific VO2max o f 
the lower limb during cycling exercise. As mass-specific cycling VO2max did not achieve 
the level o f  MitoVO2max, it was concluded that cycling VO2max was limited by O2 supply. 
However, utilization o f the cycling exercise paradigm leaves uncertainty as to the 
proportion of the lower-limb muscle mass that was actually maximally recruited in this 
study (Lollgen et al., 1980; Green & Patla, 1992). Therefore, it is unclear whether the 
low mass-specific cycling VO2max was due to limited O2 delivery, as suggested, or simply 
due to an overestimation o f the amount o f  muscle mass that was maximally recruited 
during cycling. As physical activity is recognized to greatly increase mitochondrial 
capacity, an additional, potentially confounding, factor that may have yielded conflicting 
results in this area is the training status of the subjects. Indeed, it seems possible that 
endurance-training, which consistently results in a relatively small increase in VO2max 
compared to the large documented increase in mitochondrial capacity (Gollnick et al., 
1973), may result in a mitochondrial reserve capacity that shifts the bottleneck at VO2max 
away from the mitochondria toward processes related to O2 supply.
Therefore, with the concept of symmorphosis in mind, the purpose of this study 
was to determine the role of O2 supply and demand in determining VO2max in trained and 
untrained humans using an exercise model with well-defined muscle recruitment 
(Richardson et al., 1998). Specifically, MitoVO2max of permeabilized muscle fibers, from 
the vastus lateralis, were compared to maximum rates of O2 delivery and VO2, assessed 
by the direct Fick method, during maximal KE exercise in trained and untrained subjects.
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We hypothesized that KEVO2max of the untrained subjects would reach MitoVO2max, 
implicating mitochondrial O2 demand as the limitation to VO2max in these subjects. 
Conversely, we further hypothesized that, as a result of endurance training-induced 
mitochondrial biogenesis, trained subjects would exhibit a disproportionately high 
MitoVO2max, which would not be reached at KEVO2max, implicating O2 supply as a 
determinant of VO2max in these subjects. If these hypotheses were proven to be correct, 
this study would shed additional light on the concept of symmorphosis, as it relates to 
VO2max in humans, revealing a lack this phenomenon in both untrained and trained 
subjects, but due to very differing constraints.
Methods
Subjects
Following approval by the Institutional Review Board at the University of Utah 
and the Salt Lake City Veterans’ Hospital, 10 young, healthy untrained males and 10 
young, healthy, endurance-trained male subjects were recruited for this study and 
provided informed, written consent. The untrained subjects were selected based upon a 
self-reported lack of moderate-to-vigorous physical activity over the past 2  years, while 
the trained subjects reported regularly participating in moderate-to-vigorous physical 
activity and endurance training (e.g., cycling, running, skiing) over the past 2  years.
Muscle O2 Delivery and Muscle VO2max in vivo 
Familiarization Sessions
Prior to the main experiment, subjects underwent multiple familiarization visits to 
become accustomed to performing KE exercise on a custom built knee extension
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ergometer and cycling exercise on a commercially available cycle ergometer (Lode, 
Netherlands). Once familiar with the exercise modalities, the maximum work rate 
(WRmax) a subject could sustain for 1 minute at the end of maximal graded cycle and KE 
exercise test was assessed. Specifically, for both cycling and KE exercise, subjects were 
given a 2-3 minute warm-up which was followed by an increment in WR (KE: 5 W, 
Cycling: 25 W) each minute until task failure (i.e. inability to maintain 60 rpm during KE 
exercise or falling to 50 rpm from a >60 rpm from a self-selected cadence during 
cycling). In order to ensure a test duration of 8-12 minutes, the starting workload for 
both exercise modalities was tailored to each subject’s ability. Additionally, BodyVO2max 
was assessed during the cycling WRmax test utilizing an indirect calorimetry system 
(Parvomedics, UT, USA), and was defined as the highest rate of O2 consumption 
averaged over 30 seconds prior to cessation of exercise (Garten et al., 2014).
Experimental Protocol
On the day of the exercise portion of the experiment, subjects performed KE 
exercise at 25, 50, 75, 90, 100% of WRmax for 2-3 minutes each (Richardson et al., 1995), 
during which muscle VO2 of the leg was assessed by the direct Fick method. 
Specifically, muscle VO2 was calculated as the product of femoral blood flow and the 
arterial-venous O2 difference (VO2 = Femoral Blood Flow * a-v O2 difference). Femoral 
blood flow was assessed via Doppler ultrasound of the common femoral artery (CFA), 
proximal to the exercising quadriceps femoris, while arterial and venous O2 content was 
assessed by a blood gas analyzer (GEM 4000, Instrumentation Laboratories, Bedford, 
MA, USA) on blood drawn through catheters placed directly in the CFA and common 
femoral vein (CFV), as described below. Subsequently, QO2 to the muscle was
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calculated as the product o f  femoral blood flow and arterial O2 content. Heart rate was 
assessed at rest and throughout the test with a standard three-lead ECG. Femoral artery 
blood pressure was measured continuously at rest and during exercise with an indwelling 
catheter placed in the CFA with a pressure transducer set at the level o f  the catheter. 
Subsequently, heart rate, blood pressure and power output data were recorded with a data 
acquisition system (Biopac, Goleta, Ca).
Doppler Ultrasound Assessments
Measurements o f  CFA blood velocity and artery diameter, 2-3 cm proximal to the 
superficial/deep bifurcation, were taken using a Logiq 7 ultrasound Doppler system in 
duplex mode (General Electric Medical Systems, Milwaukee, WI) equipped with a linear 
array transducer function at an imaging frequency of 14 MHz. CFA blood velocity was 
assessed with the same probe with a Doppler frequency of 5 MHz operated in the high- 
pulsed repetition frequency mode (2-25mHz), as described previously (Barrett-O'Keefe et 
al., 2013). Blood velocity was assessed with an insonation angle of no more than 60° 
(Harris et al., 2010) while the sample size was maximized and centered according to 
vessel size and position in real time. All ultrasound data were calculated using Logiq 7 
software. Ultimately, femoral blood flow was calculated with the following equation: 
Femoral Blood Flow = [mean blood velocity *n(vessel diameter/2)2 * 60].
Blood Analysis
Three milliliters of blood were drawn at rest and during the last minute of each 
exercise stage through catheters placed in the CFA and CFV. Approximately 1 ml o f 
blood was analyzed for arterial and venous total hemoglobin (tHb) content, hemoglobin
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saturation (HbO2), and PO2 using a GEM 4000 blood gas analyzer and cooximeter 
(Instrumentation Laboratories, Bedford, Ma). Arterial and venous blood O2 content was 
calculated with the following equation: Blood O2 Content (in ml/dl) = [1.39(tHb) * 
(HbO2 saturation/100)] + (0.003 * PO2)] . The remainder of blood drawn was taken and 
preserved for further analysis.
Determination of Leg Muscle Mass
Muscle volume of the lower limb was assessed by multiple measurements of thigh 
and leg circumference and skin fold thickness as described by Layec et al. (2014), who 
documented that this simple estimate of muscle volume demonstrates a very strong 
correlation with volume measured by MRI across a broad spectrum of subjects (r2=0.89- 
0.98). Muscle mass of the thigh and leg were then determined by assuming a muscle 
density of 1.049kg/L (Kemp et al., 2015). Finally, the mass of the quadriceps femoris 
was subsequently calculated as described by Jones and Pearson (1969), while applying 
the correction factor recommended by Radegran et al. (1999).
Determination of Mitochondrial VO2max In Vitro
Muscle Biopsy
Subjects reported to the laboratory for a muscle biopsy (approximately 1 week 
before or after the exercise/catheter portion of the study) in a fasted state and having 
refrained from vigorous exercise for 24 hours. Muscle samples of the vastus lateralis 
were obtained by a percutaneous needle biopsy 15 cm proximal to the knee at a depth of 
~3.5 cm under sterile conditions (Richardson et al., 2004). Immediately after the muscle 
sample (~150 mg) was removed from the leg, ~20% of the sample was immersed in ice-
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cold biopsy preservation fluid (BIOPS) for respiratory analysis (Pesta & Gnaiger, 2012), 
while the other portion was snap frozen and stored at -80°C for histological and 
biochemical analyses.
Mitochondrial Respiration
Muscle samples were prepared and permeabilized as described by Pesta et al. 
(2012). Briefly, BIOPS-immersed fibers were carefully separated with fine-tip forceps 
and subsequently bathed in a BIOPS-based saponin solution (50^g saponin/ml BIOPS) 
for 30 minutes. Following saponin treatment, muscle fibers were rinsed twice in ice-cold 
mitochondrial respiration fluid (MIR05) for 10 minutes each rinse. The wet weight of 
each muscle sample (~3-4mg) was then assessed on a calibrated scale after excess fluid 
had been removed from the sample by dabbing the muscle several times with a paper 
towel.
Muscle fibers were then placed in the temperature-controlled respiration chamber 
(Oxytherm, Hansatech Instruments. Norfolk, UK) in 2 ml MIR05 solution and warmed 
to 37°C. After allowing the muscle 10 minutes to equilibrate, mitochondrial respiration 
was assessed in duplicate as described below. State 2 respiration was assessed with 
malate (2mM) + glutamate (10mM), followed by State 3:CI respiration with ADP 
(5mM). Subsequently, succinate (10mM) was added to assess State 3:CI+CII respiration, 
which represented MitoVO2max. Finally, cytochrome C (10uM) was added to the bath to 
verify membrane integrity as recommended by Pesta et al. (Pesta & Gnaiger, 2012). 
Each respiration state or step lasted as long as required to produce a steady state 
respiration rate, which was approximately 3 minutes in most cases. Background 
respiration inherent to the experimental setup was measured and taken into account when
assessing overall mitochondrial respiration. As the respirometer offered the greatest 
temperature stability at 37°C, but exercise generally results in an increase in muscle 
temperature from 37°C to 38+°C (Saltin et al., 1968; Kenny et al., 2003), respiration 
rates were obtained with the muscle sample at 37°C and then mathematically adjusted, 
based on a Q10 of 2 (multiplication factor for O2 consumption at a 10°C difference), to 
yield predicted values at 38°C (Rasmussen et al., 2001; Boushel et al., 2011). The 
respiration data for each of the two separate muscle fiber samples were then averaged.
Statistical Analyses
Differences in O2 delivery, O2 consumption, and O2 extraction during KE exercise 
were assessed with two-way, repeated measures ANOVA, which, when significant, was 
followed by a Tukey’s post hoc test (SPSS version 17. Chicago, Il). Differences in 
variables between groups, such as subject characteristics and maximum values, were 
tested with an independent samples T-test. Correlations between variables were assessed 
with Pearson product-moment correlations. Alpha was set at 0.05 a priori.
Results 
Subject Characteristics 
Ten young, healthy, untrained and trained male subjects were successfully 
recruited and completed this study. As documented in Table 4.1, the subjects in both 
groups were well matched, except, by experimental design, as a consequence of exercise 
training, there was a clear difference in exercise capacity assessed by BodyVO2max. 
Specifically, BodyVO2max in the untrained ranged from 31-44 ml/kg/min and the trained 
ranging from 54-66 ml/kg/min. This difference in BodyVO2max was also apparent in
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absolute terms (i.e., BodyVO2max in L/min) and reflected in both cycle and KE exercise 
WRmax, for each o f  which the untrained subjects were significantly lower than the trained 
subjects. Interestingly, although not achieving statistical significance, morphometric 
analyses of the vastus lateralis revealed a tendency for the untrained subjects to have a 
lower % of Type I skeletal muscle fibers and a greater % of Type II than the trained 
subjects, and no difference in the number o f  capillaries around a fiber (NCAF).
Response to KE Exercise 
As illustrated in Figure 4.1A, mass-specific VO2 during KE exercise increased 
with each increase in WR (P<0.05) until WRmax, except for the change in VO2 from 90 to 
100 % of KE exercise WRmax which did not achieve significance in either the untrained 
or trained subjects. As expected, the trained subjects achieved significantly greater rates 
o f  muscle O2 consumption compared to untrained subjects during KE exercise, both in 
absolute (untrained: 641±41 ml/min; trained: 858±55 ml/min) or relative terms (Figure 
4.1A). Femoral artery blood flow (Figure 4.1B) followed a very similar pattern to VO2, 
with clear increments at each WR, except from 90-100% o f KE exercise WRmax, and 
ultimately attaining significantly greater values at KE exercise WRmax in the trained 
subjects compared to the untrained subjects. a-v O2 difference (Figure 4.1C) did not 
exhibit an increase with each KE exercise WR, in fact, in the untrained subjects 
extraction failed to increase beyond that achieved at 50% o f WRmax. Interestingly, 
although also failing to increase O2 extraction with each workload, the trained subjects 
exhibited a greater propensity for extracting O2 by increasing a-v O2 difference at WRmax 
beyond that achieved at 75%WRmax. Ultimately, a-v O2 difference was significantly 
greater at KE exercise WRmax in the trained subjects compared to the untrained subjects.
Utilization of Mitochondrial Capacity during KE Exercise 
and Whole-Body Exercise 
As is commonly observed with endurance training, muscle samples from 
endurance-trained subjects exhibited a significantly greater MitoVO2max than untrained 
subjects (743 ± 35 and 364±16 ml/kg/min, respectively; Figure 4.2A). As illustrated in 
Figure 4.2, in untrained subjects KEVO2max (340±21 ml/kg/min) was not significantly 
different than MitoVO2max (P>0.05), while maximum O2 delivery during KE exercise 
(KEQO2max, 462±37 ml/kg/min) exceeded MitoVO2max (P<0.05). In contrast, in the trained 
subjects KF.QQ7.1max (557±35 ml/kg/min) and subsequently KEVO2max (458±24 ml/kg/min) 
were both significantly lower than MitoVO2max (P<0.05). Of note, an increase in 
MitoVO2max was associated with a proportionate increase in KEVO2max among the 
untrained subjects (r=0.69, P<0.05), but not in the trained subjects (r=0.01, P=0.74, 
Figure 4.3). Interestingly, as illustrated in Figure 4.4, the untrained subjects exhibited a 
strong positive relationship between MitoVO2max and BodyVO2max, while, again in contrast 
to the untrained subjects, the trained exhibited no relationship between MitoVO2max and 
BodyVO2max (r=0.12, P=0.74).
Discussion
The extent to which VO2max represents the maximal capacity of each step of the 
O2 cascade and therefore conforms to the postulate of symmorphosis, or which step, if 
any, limits VO2max is keenly debated. This study, utilized a unique combination of in 
vitro and in vivo measures of respiratory capacity in both exercise-trained and untrained 
subjects to better elucidate the determinants of VO2max in humans. Together these 
measures reveal clearly differing determinants of VO2max in untrained and trained
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humans. Specifically, in the untrained, there is evidence against symmorphosis, with 
VO2max being determined by mitochondrial O2 demand. While, in contrast, trained 
subjects, who also fail to fit the postulate of symmorphosis, exhibit an exercise training- 
induced mitochondrial reserve that results in skeletal muscle VO2max in vivo being O2 
supply limited. Supportive of these differing determinants of VO2max, in untrained 
subjects, pulmonary VO2max assessed during more traditional whole-body cycling 
exercise revealed a strong and significant relationship to muscle mitochondrial VO2max 
measured in vitro, while these two variables were entirely unrelated in the trained 
subjects. Thus, as VO2max was suppressed by discrete, albeit different, portions of the O2 
cascade in exercise-trained and untrained humans, it appears that, in contrast to the 
premise of symmorphosis, the capacity of each component of the O2 cascade is not 
expressed in strict proportion toVO2max.
Utilization of Mitochondrial Capacity during KE Exercise 
In order to gain insight into the extent to which untrained and trained subjects 
utilize their entire mitochondrial capacity during exercise, we compared MitoVO2max to 
KEVO2max. KE exercise is a small-muscle-mass model that isolates an easily quantifiable 
muscle mass (Richardson et al., 1998) and provides an experimental paradigm that lends 
itself to the assessment of blood flow and blood samples across the exercising muscle 
group, even at maximal exercise. Given the minimal strain that KE exercise places on 
central factors, such as the lungs and heart, we anticipated that if  subjects were to reach 
MitoVO2max, in vivo, during some form of exercise, it would likely be KE exercise when 
pulmonary O2 diffusion and cardiac output are not likely to be limiting. As illustrated in 
Figure 4.1, KE exercise yielded high maximal rates of O2 consumption, which were
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greater in the trained compared to the untrained subjects. As hypothesized, during KE 
exercise the untrained subjects were able to exercise to the point where KEVO2max reached 
MitoVO2max (Figure 4.2B). Indeed, these untrained subjects utilized 94±4% of their 
mitochondrial respiratory capacity during maximal KE exercise. Furthermore, within 
these untrained subjects KEVO2max and MitoVO2max were well related (r=0.69, P<0.05, 
Figure 4.3). Thus, in combination, these data imply that mitochondrial respiratory 
capacity limits KEVO2max in untrained subjects. The trained subjects achieved 
significantly greater rates of O2 consumption during KE exercise than the untrained 
subjects, but the increase in KEVO2max was not proportionate to the large increase in 
MitoVO2max, which was nearly double that of the untrained subjects. Consequently, the 
trained subjects were only able to utilize 63±4% of their far greater MitoVO2max during 
maximal KE exercise (Figure 4.2B), suggesting that mitochondrial capacity was likely 
not limiting VO2 max in these subjects.
Based on the observation that QO2max failed to reach similar O2 flux rates as 
MitoVO2max among trained subjects (Figure 4.2A), it is likely that limited O2 delivery 
prevented the trained subjects from reaching MitoVO2max during maximal KE 
exercise. This is further supported by the lack of a relationship between MitoVO2max and 
KEVO2max in the trained subjects and contrasts starkly with the significant relationship 
exhibited by untrained subjects (Figure 4.3). Specifically, if  the mitochondria were a 
limiting factor in KEVO2max it would be reasonable to expect that across subjects with 
differing levels of MitoVO2max there would be a concomitant change in KEVO2max, but this 
was apparent only in the untrained subjects. In the trained subjects there was no such 
relationship, implying that for trained subjects a factor upstream from the mitochondria,
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in the O2 cascade, is limiting KEVO2max.
Thus, it appears that mitochondrial respiratory capacity limits KEVO2max in 
untrained subjects, while in trained subjects there is evidence of a mitochondrial reserve 
capacity. These differing constraints to VO2max in trained and untrained humans during 
KE exercise may help to explain the contradictory findings on the effects o f  hyperoxia on 
KEVO2max that have been reported (Pedersen et al., 1999; Richardson et al., 1999). For 
example, with untrained subjects, Pedersen et al. (1999) found that augmenting O2 
delivery by way of hyperoxia had no effect on KEVO2max. Based on the current data, it 
makes intuitive sense that there was no effect as the untrained subjects appear to already 
be operating at MitoVO2max in normoxic conditions. In contrast, when studying the effects 
of hyperoxia on KEVO2max in well-trained cyclists, Richardson et al. (1999) reported that 
hyperoxia significantly augmented KEVO2max by 17%. This finding is also in agreement 
with the current data, which indicate that trained subjects, who exhibit a significant 
mitochondrial reserve capacity under normoxic conditions, have the additional 
mitochondrial in place to consume the extra O2 available in hyperoxia.
The current relationship between MitoVO2max and KEVO2max in the untrained 
subjects is supported by data from Rasmussen et al. (Rasmussen et al., 2001) and 
Blomstrand et al. (Blomstrand et al., 1997) who reported that in vitro measures of 
skeletal muscle mitochondrial capacity parallel KEVO2max. O f note, in addition to 
reporting that several indices o f  muscle metabolism exhibited good agreement with 
KEVO2max, Rasmussen et al. (Rasmussen et al., 2001), somewhat surprisingly, also found 
that MitoVO2max, assessed in isolated mitochondria, was lower than KEVO2max. This 
observation, which disagrees with the current, more intuitive findings, is unlikely to say
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the least. This physiologically improbable scenario, may have been the result of altered 
mitochondrial function, inherent to the isolated mitochondria technique (Picard et al., 
2011), or inflated blood flow measurements, attained by the thermodilution technique, 
that would result in an overestimation of KEVO2max.
Utilization of Mitochondrial Capacity during Whole-body Exercise 
Recognizing the atypical nature of KE exercise and the minimal strain placed 
upon central factors, such as the lungs and heart, with this exercise modality, BodyVO2max 
during traditional cycle exercise was also assessed and compared with MitoVO2max in these 
trained and untrained subjects. In support of the findings with KE exercise, as illustrated 
in Figure 4.4, the relationship between MitoVO2max and BodyVO2max, again very clearly, 
reveals that training status affects the relationship between respiratory capacity measured 
in vitro and whole body metabolic capacity during cycling. Indeed, as was the case for 
KEVO2max, but even more clearly, MitoVO2max appears to have a significant influence on 
BodyVO2max in the untrained subjects during cycling. Specifically, across the untrained 
subjects, there was a strong positive relationship, such that each increase in MitoVO2max 
was mirrored by a proportional increase in BodyVO2max. Thus, in addition to the current 
KE exercise data and previous studies (Roca et al., 1992; Cardus et al., 1998) these 
findings support the conclusion that during exercise untrained subjects are limited by 
mitochondrial O2 demand.
In contrast to the untrained, as was the case with KE exercise, among the trained 
subjects, an increase in MitoVO2max did not result in an increase in BodyVO2max. In 
agreement with prior studies utilizing cycling exercise (Roca et al., 1992; Knight et al., 
1993), this finding suggests that, when exercise trained, mitochondrial capacity does not
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dictate or limit BodyVO2max. Indeed, increasing QO2 has an effect on cycling VO2max in 
trained subjects, who exhibit an 8% increase in cycling VO2max when breathing 100% O2 
(Knight et al., 1993). However, as already recognized, O2 supply does not appear to be 
limiting in untrained subjects, as increasing, or even mildly decreasing O2 supply has no 
effect on cycling VO2max (Roca et al., 1992; Cardus et al., 1998). This divergence in the 
determination of VO2max in untrained and trained subjects has also been observed in 
longitudinal studies of subjects before and after endurance training, supporting the idea 
that training is at the root of the differing constraints to VO2max (Roca et al., 1992).
Interestingly, as already acknowledged, in disagreement with the current study, 
Boushel et al. (Boushel et al., 2011) reported that cycling VO2max did not reach the level 
of MitoVO2max in untrained subjects and thus there was an apparent mitochondrial excess 
during maximal cycling exercise. The discrepancy between the current study and that of 
Boushel et al. (Boushel et al., 2011) could be related to differences in the aerobic fitness 
of the untrained subjects (i.e., BodyVO2max), which was not reported by Boushel et al., or 
alternatively, may be related to an overestimation of the active muscle mass during 
cycling exercise. As is common practice (Richardson et al., 2004; Mortensen et al., 
2005), these authors normalized the absolute VO2 across the leg during cycling by the 
entire muscle mass of the lower limb, assuming that all muscles of the lower limb were 
maximally recruited during the exercise, which may not be the case (Lollgen et al., 1980; 
Green & Patla, 1992). In addition to the, already recognized, hypoxic/hyperoxic studies, 
which agree with the current study (Roca et al., 1992; Cardus et al., 1998), the concept 
that mitochondrial O2 demand, and not O2 supply, limits VO2max in untrained subjects is 
further supported by recently published data from Jacobs et al. (2013). In this study the
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authors documented that the cycle exercise training-induced increase in VO2max of 
previously sedentary subjects was related to augmented mitochondrial respiratory 
capacity and not O2 delivery.
Determinants of VO2max in Untrained and Trained Subjects 
This study provides convincing evidence that VO2max in untrained subjects is 
determined by the capacity of skeletal muscle mitochondria to consume O2, while, in 
contrast, VO2max in trained subjects can be attributed to an O2 supply limitation to the 
exercising muscle. In terms of limited O2 demand, although some differences in the 
mitochondrial quality of trained and untrained subjects have been reported (Jacobs & 
Lundby, 2013), it seems most likely that O2 demand limitation among the untrained is the 
consequence of differences in mitochondrial density rather than a mitochondrial defect. 
In term of O2 supply limitation, as exhibited by the trained subjects, it is recognized that 
the term O2 supply is rather general and covers multiple steps of the O2 cascade, 
including O2 diffusion across the lungs, O2 carriage in the blood, delivery of blood born 
O2 to active muscle and, finally, the diffusion of O2 into the muscle, all of which may 
contribute to the O2 supply limitation. Although, central limitations, such as pulmonary 
diffusion and cardiac output, have been reported to limit O2 supply during maximal 
exercise (Dempsey et al., 2008; Levine, 2008), the capacity of these factors is unlikely to 
have been exhausted during KE exercise, a small muscle mass model (Richardson & 
Saltin, 1998). Therefore, as KE exercise was the main modality of choice in the current 
study, it appears that peripheral factors like capillary-muscle diffusion (Richardson et al., 
1995) or the ability of the vascular system to transport O2-rich blood to the exercising 
muscle may contribute to the discrepancy between VO2max and MitoVO2max in the trained
subjects. The potential for a limitation in terms of vascular conductance is of particular 
interest to our group, as we have recently published evidence that suggests that 
vasodilation during exercise may be limited by Endothelin-1 to guard against 
hypotension (Barrett-O'Keefe et al., 2013), but it is not yet known how this is affected by 
exercise training.
Implications o f  a Mitochondrial Reserve Capacity 
Although mitochondrial respiratory capacity, at maximal KE exercise, in the 
trained subjects appears to be in excess, it is likely that this reserve capacity has some 
other function. Indeed, Gollnick and Saltin (1982) postulated that increasing 
mitochondrial enzyme capacity, even without increasing VO2max, would have profound 
effects on endurance performance, by increasing fatty acid utilization, and the subsequent 
sparing o f glycogen. Additionally, some have suggested that mitochondrial reserve 
capacity may be advantageous as this likely distributes the metabolic work demanded by 
exercise across a broader network o f  mitochondria. Thus, no single mitochondrion would 
be required to operate at a maximal rate, allowing the mitochondria to buffer additional 
stresses that may be encountered (Sansbury et al., 2011).
With this model in mind, when confronted with a metabolic challenge, untrained 
subjects without a mitochondrial reserve capacity would be more likely to show outward 
manifestations of this stress (e.g., mitochondrial dysfunction, exercise intolerance, etc.) 
than exercise-trained subjects who could buffer such an insult with their mitochondrial 
reserve. In fact, studies examining mitochondrial reserve capacity in animal models and 
cultured cells, like cardiomyocytes and fibroblasts, have reported that cells with a greater 
mitochondrial reserve are more resistant to oxidative-stress-induced mitochondrial
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dysfunction (Sansbury et al., 2011), defects due to mitochondrial toxins (Fern, 2003), and 
cell death (Nickens et al., 2013) than cells with little-to-no reserve capacity. As 
BodyVO2max, which was associated with a greater mitochondrial reserve capacity in the 
current study (Figure 4.4), has been associated with decreased rates of mortality 
(Laukkanen et al., 2001) and resistance to disease (Koch et al., 2011; Overmyer et al., 
2015), it seems likely that some of the protective effects associated with aerobic fitness 
may be conferred through this excess capacity and would be worthy of further study.
Conclusion
The unique combination of in vivo and in vitro measures utilized in this study 
reveal differing factors that determine VO2max in untrained and trained humans and 
therefore question the premise of symmorphosis in this important process. Specifically, 
in the untrained, who utilize their entire mitochondrial capacity during maximal KE 
exercise, there is evidence against symmorphosis, with VO2max being determined by 
mitochondrial O2 demand. While, in contrast, trained subjects exhibit an exercise 
training-induced mitochondrial reserve that results in skeletal muscle VO2max, in vivo, 
being O2 supply limited, which also fails to fit the postulate of symmorphosis.
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Table 4.1: Characteristics of U ntrained and Trained Subjects
U ntrained Trained P
Subjects (n) 10 10
Age (years) 25 ± 4 24 ± 2 0.77
BM I (kg/m2) 25 ± 1 23 ± 1 0.20
BodyVO2max (L/min) 2.9 ± 0.2 4.1 ± 0.2* 0.001
BodyVO2max (ml/kg//min) 38 ± 2 59± 1 0.001
Cycling WRmax (W atts) 243 ± 38 359± 63* 0.001
KE exercise WRmax (W atts) 45 ± 7 70 ± 5* 0.001
Total Leg Muscle Mass (kg) 6.35 ±0.3 6.46 ±0.3 0.45
Quadriceps Muscle Mass 1.94 ± 0.1 2.0 ±0.1 0.64
(kg)
Muscle Fiber Type I (% ) 38 ± 7 51 ± 6 0.20
Muscle Fiber Type II  (% ) 62 ± 7 49 ± 6 0.20
NCAF 3.0 ± 0.5 3.0 ± 0.1 0.45
* Significantly different than untrained. Body Mass Index, BMI; Whole body maximal 
oxygen consumption assessed on a cycle ergometer, BodyVO2max; Work rate maximum, 
WRmax; Knee extensor exercise, KE; Number of Capillaries Around a Fiber, NCAF.
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Figure 4.1: Oxygen consumption, femoral blood flow and arterial-venous oxygen 
difference during knee extensor (KE) exercise in untrained and trained subjects. #















Figure 4.2: Utilization of m itochondrial respiratory capacity during maximal knee 
extensor (KE) exercise A.) Maximal oxygen consumption (KEVO2max) and delivery 
(KEQO2max) during maximal KE exercise in trained and untrained subjects compared to 
the maximal mitochondrial oxygen consumption (mitoVO2max) of permeabilized fibers 
from the vastus lateralis in the same subjects. B.) Percent utilization of mitochondrial 
capacity (% mitoVO2max) during maximal KE exercise in untrained and endurance-trained 
subjects. Note, the dotted line in Panel B represents the theoretical point where the full 
respiratory capacity of the mitochondria are utilized during KE exercise (i.e., 100% 
MitoVO2max) * significantly different from mitoVO2max. # Significantly different from 
untrained subjects.
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Figure 4.3: Evidence of a relationship between maximal m itochondrial oxygen 
consumption (MitoVO2max) and maximal oxygen consumption during knee extensor 
(KE) exercise (KEVO2max) in untrained, but not trained subjects. The dotted line 
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Figure 4.4: Evidence of a relationship between maximal m itochondrial oxygen 
consumption (MitoVO2max) and whole-body oxygen consumption (BodyVO2max) in 




During dynamic exercise the active muscles require greater quantities of ATP to 
power muscle contraction and maintain cell function (Richardson, 2003). As much of 
this ATP is resynthesized by mitochondria in the muscle, the function of the 
mitochondria is crucial to the health and performance of the muscle. Given the essential 
role that O2 plays in mitochondrial resynthesis of ATP, it is equally crucial that a 
sufficient supply of O2 is delivered to the mitochondria by the cardiopulmonary system.
In view of the critical roles of these processes in maintaining function during exercise, 
this dissertation sought to elucidate the regulation of skeletal muscle O2 supply and 
demand and determine their influence on physical function in the context of health and 
disease.
In the first study, motivated by the theory that heat generated by an exercising 
muscle attunes O2 supply to metabolic demand, we sought to explore the mechanisms by 
which physiologically-relevant levels of heat inhibit a-adrenergic vasocontraction. 
Interestingly, we found that a 1-adrenergic vasocontraction was more clearly inhibited by 
heat than a2-adrenergic vasocontraction. Additionally, we found that this 
sympathoinhibitory effect of heat could be prevented by inhibiting the temperature- 
sensitive, TRPV4 ion channels or by denuding the endothelium. Thus, we concluded that 
TRPV4 ion channels present in isolated skeletal muscle feed arteries respond to heat, 
typical of the muscle during exercise, to inhibit a 1-adrenergic vasoconstriction in an 
endothelium-dependent manner. While these studies were performed in an isolated 
model, given the potential for feed arteries to regulate blood flow to a muscle (Ives et al., 
2 0 1 2 b), it is possible that such mechanisms contribute to functional sympatholysis in 
vivo. In light of the importance of O2 supply and demand highlighted in the third study of
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this dissertation, it seems appropriate and efficient that mechanisms directly linked to the 
metabolism of the muscle itself calibrate O2 supply to metabolic demand.
In the second study we sought to determine if  qualitative changes in 
mitochondrial respiratory function (i.e., O2 demand) contribute to the exercise intolerance 
exhibited by patients with COPD. Indeed, the muscle of patients with COPD exhibited a 
lower peak respiration and an altered pattern of respiration compared to healthy, age- 
matched controls. Notably, the mitochondria of patients with COPD exhibited a 
diminished capacity for CI-driven respiration and an increased reliance on CII-driven 
respiration (i.e., reduced CI/CII) compared to controls. Importantly, those patients who 
exhibited a lower CI/CII fatigued earlier during KE than those who exhibited a greater 
CI/CII, supporting the notion that this qualitative alteration in mitochondrial respiration 
contributes to the exercise intolerance typical of patients with COPD. Indeed, as CII- 
driven respiration demands more O2 to resynthesize ATP than CI-driven respiration, this 
altered respiratory profile may partially explain the increased O2 cost of exercise that is 
thought to play a role in the exercise intolerance of these patients (Richardson et al.,
2004; Medeiros et al., 2014). As comorbidities common to COPD (e.g., pulmonary 
diffusion limitation and increased work of breathing) often lead to a reduced supply of O2 
to the exercising muscle (Knower et al., 2001; Dempsey et al., 2006), this less-efficient 
respiratory pattern, which likely exaggerates the O2 cost of exercise, may be particularly 
debilitating in patients with COPD.
In the third study, inspired by the theory of symmorphosis, which postulates that 
the capacity of each step of the O2 cascade is attuned to the task required at VO2max such 
that no single step restrains VO2max, we investigated the roles of O2 supply and O2
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demand in determining VO2max by comparing in vivo (skeletal muscle VO2max, direct 
Fick) and in vitro (permeabilized muscle fiber mitochondrial VO2max) measures of 
respiratory capacity. As endurance training is known to influence both O2 supply and 
demand (Gollnick et al., 1973; Levine, 2008) we sought to determine if the limitations of 
VO2max differed between untrained and endurance-trained subjects. The unique 
combination of in vivo and in vitro measures utilized in this study revealed that differing 
factors limit VO2max in untrained and trained humans and therefore question the premise 
of symmorphosis in this important process. Specifically, in the untrained, who utilize 
their entire mitochondrial capacity during maximal KE exercise, there is evidence against 
symmorphosis, with VO2max being limited by mitochondrial O2 demand. Conversely, the 
trained subjects, who also fail to fit the premise of symmorphosis, exhibit an exercise 
training-induced mitochondrial reserve that results in skeletal muscle VO2max, in vivo, 
being limited by O2 supply.
The greater understanding of the roles of O2 supply and O2 demand in limiting 
VO2max provided by the third study sheds light on the importance and relevance of the 
findings of the other two studies. First, the strong influence of O2 supply on VO2max in 
the endurance-trained highlights the importance of attuning the delivery of O2-rich blood 
to the metabolic demand of exercising muscle through functional sympatholysis. Indeed, 
it has been documented that inefficient sympatholysis can hinder physical function 
(Saltin & Mortensen, 2012), and, again, based upon the fact that endurance-trained 
individuals were strongly limited by O2 supply, the influence of such sympatholytic 
systems on performance would likely be magnified in these O2-limited individuals. 
Second, the fact that the VO2max of untrained individuals was limited by mitochondrial O2
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demand highlights the significance o f  the decreased respiratory capacity and function 
exhibited by patients with COPD. Specifically, it has been suggested that the 
mitochondria are in excess, even among untrained individuals (Boushel et al., 2011; 
Boushel & Saltin, 2013), such that any decrement in mitochondrial respiratory function is 
mitigated by the excess capacity. However, since there was no evidence o f  a 
mitochondrial reserve capacity in the untrained subjects, it seems likely that the 
decreased mitochondrial respiratory function of patients with COPD, who are typically 
very sedentary, would adversely impact the physical function of these patients. In 
addition to calling attention to the mitochondrial respiratory function o f patients with 
COPD, these data also highlight the potential importance of appropriate mitochondrial 
respiratory function in other untrained populations.
In summary, by utilizing a broad range o f  in vivo and in vitro methods, this 
dissertation elucidates the mechanisms that regulate O2 supply and O2 demand, and 
clarifies their impact on exercise performance in healthy young individuals, as well as 
patients with COPD, thereby highlighting the potential of these factors to serve as 
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